No full-text available
To read the full-text of this research,
you can request a copy directly from the authors.
Acclimation strategies in gilts to control Mycoplasma hyopneumoniae infection
Abstract
Mycoplasma hyopneumoniae (M. hyopneumoniae) is the primary causative agent of enzootic pneumonia (EP), one of the most economically important infectious disease for the swine industry worldwide. M. hyopneumoniae transmission occurs mainly by direct contact (nose-to-nose) between infected to susceptible pigs as well as from infected dams to their offspring (sow-to-piglet). Since disease severity has been correlated with M. hyopneumoniae prevalence at weaning in some studies, and gilts are considered the main bacterial shedders, an effective gilt acclimation program should help controlling M. hyopneumoniae in swine farms. The present review summarizes the different M. hyopneumoniae monitoring strategies of incoming gilts and recipient herd and proposes a farm classification according to their health statuses. The medication and vaccination programs against M. hyopneumoniae most used in replacement gilts are reviewed as well. Gilt replacement acclimation against M. hyopneumoniae in Europe and North America indicates that vaccination is the main strategy used, but there is a current trend in US to deliberately expose gilts to the pathogen.
... Promoting early gilt exposure to M hyopneumoniae-positive cull sows in gilt development units or implementing controlled exposure programs (intratracheal or aerosol inoculation), followed by sufficient time for the development of a robust immunity (at least 240 days) and decreased bacterial shedding, has shown to be an effective way of reducing disease in downstream populations. [5][6][7][8][9][10] The economic impact, coupled with recent diagnostic improvements, increased knowledge on the ecology of M hyopneumoniae, and availability of naive breeding stock has led to an increase in the frequency of successful M hyopneumoniae control, prevention, and elimination programs in North America. 11 The wide implementation and continued use of the porcine reproductive and respiratory syndrome virus (PRRSV) swine herd classification system since 2011, has been proven to be a valuable tool for disease management; facilitating communication between swine producers, veterinarians, diagnosticians, and breeding stock companies, monitoring the status of herds, evaluating and executing strategies for disease control and prevention, and supporting regional control and elimination efforts. ...
... The previous breeding herd classification systems developed for M hyopneumoniae were used as the foundation, as well as standards and definitions developed for the PRRSV herd status classification for consistency between systems. 8,12,16 The working group held a workshop in Hendersonville, Tennessee on November 28-29, 2018. The terminology and classification criteria approved by the working group was presented to the American Association of Swine Veterinarians (AASV) Committee on Transboundary and Emerging Diseases (CTED) at the 50 th AASV Annual Meeting in Orlando, Florida on March 9, 2019. ...
... 29 Therefore, the goal of acclimating gilts to M hyopneumoniae is to allow them to become infected early in life so they can develop immunity and decrease shedding before being introduced into the sow farm. [5][6][7][8][9][10] This reduces the number of positive piglets at weaning, which can be a predictor for M hyopneumoniae clinical disease in grow-finish populations. 3 Herds that have an acclimation program where replacement gilts are exposed to M hyopneumoniae, either naturally or through controlled exposure methods, by a maximum of 80 days of age are expected to have a low incidence of M hyopneumoniae disease in the breeding herd and are therefore considered M hyopneumoniae controlled herds. ...
A standardized system for classifying the Mycoplasma hyopneumoniae status of swine breeding herds was developed by defining a set of diagnostic guidelines to determine the exposure and shedding status of herds. The classification is based on epidemiological and ecological features of M hyopneumoniae and reflects current field control and elimination practices. The classification was developed by a working group composed of representatives from academia, industry, swine practitioners, American Association of Swine Veterinarians (AASV), and the National Pork Board, and approved by the AASV Board of Directors on October 2, 2019. Clear and concise terminology will facilitate communication across all stakeholders.
... Several strategies for elimination and control of M. hyopneumoniae infection within herds have been proposed (Holst et al., 2015;Garza-Moreno et al., 2018;Maes et al., 2018). In consequence, various approaches are used to measure the success of the control and eradication strategies and monitoring M. hyopneumoniae status, such as clinical examination, lung lesion examination by abattoir surveillance and the submission of different type of samples to monitor this bacterium, mostly serum samples and respiratory swabs (Sibila et al., 2009;Pieters et al., 2017;Garza-Moreno et al., 2018). ...
... Several strategies for elimination and control of M. hyopneumoniae infection within herds have been proposed (Holst et al., 2015;Garza-Moreno et al., 2018;Maes et al., 2018). In consequence, various approaches are used to measure the success of the control and eradication strategies and monitoring M. hyopneumoniae status, such as clinical examination, lung lesion examination by abattoir surveillance and the submission of different type of samples to monitor this bacterium, mostly serum samples and respiratory swabs (Sibila et al., 2009;Pieters et al., 2017;Garza-Moreno et al., 2018). ...
... Farm selection was based on prior history of M. hyopneumoniae infection, upon consultation with the herd veterinarian. Farms were classified according to their M. hyopneumoniae health status (Garza-Moreno et al., 2018). Farm A was a M. hyopneumoniae negative farm with absence of clinical signs and record of negative samples from the last 15 years. ...
There is a need to develop cost-effective and non-invasive approaches to sample large populations to evaluate the disease status of breeding herds. In this study we assessed the presence of the Mycoplasma hyopneumoniae genetic material in environmental surfaces and air of farrowing rooms, and skin (udder, snout and vagina) of lactating sows at weaning, in farms having different M. hyopneumoniae infection status (negative, positive sub-clinically infected and positive clinically affected). M. hyopneumoniae was detected in air, air deposition particles, dam and stall surfaces of the positive clinically affected herd. M. hyopneumoniae could only be detected in dam and stall surfaces in sub-clinically infected herds. M. hyopneumoniae was not detected in all samples collected in the negative herd. The cycle threshold of the positive PCR samples were not statistically different between sample types or farms. However, a significant difference (p < 0.05) was observed in the percentage of positive samples between the positive clinically affected farm and the rest. Likewise, M. hyopneumoniae was detected in the environment and surfaces at weaning in positive breeding herds. Further testing and validation is recommended for environmental and surface samples before they can be employed as part of the M. hyopneumoniae diagnostic process. In addition, results from this study highlight potential sources of M. hyopneumoniae infection for piglets in breeding herds, especially during an outbreak.
... Therefore, an adequate gilt acclimation pursues the elimi nation of bacterial shedding at first farrow ing to minimize piglet colonization and later problems in the growing phase. 15,16 Vaccination is the main strategy used for re placement gilt acclimation procedures against M hyopneumoniae in both Europe and North America. 16 Vaccination protects the gilts although it does not stop them from being infected and shedding the organism. ...
... 15,16 Vaccination is the main strategy used for re placement gilt acclimation procedures against M hyopneumoniae in both Europe and North America. 16 Vaccination protects the gilts although it does not stop them from being infected and shedding the organism. 17,18 Another frequently used acclimation strategy is direct contact with pigs that are suspected to be infected. ...
... 15 Information on gilt acclimation strategies for M hyopneumoniae is limited; a recent review has pointed out that vaccination is the main strategy used in Europe, Mexico, and the United States. 16 Vaccination of gilts for M hyopneumoniae at acclimation may be effective to decrease shedding and infectious pressure, 29 how ever, studies under experimental 18 and field conditions 7,30 showed that vaccination did not prevent infection and transmission of the pathogen. To control the time of infec tion with M hyopneumoniae and minimize the likelihood of bacterial shedding at the first farrowing, early controlled exposure has been attempted by administering lung tissue homogenate containing M hyopneumoniae to replacement gilts. ...
Objective: This study assessed the efficacy of nebulization (NEB), also known as fogging, to expose gilts to Mycoplasma hyopneumoniae under field conditions as a potential acclimation strategy. Materials and methods: Phase I consisted of 448 M hyopneumoniae-free gilts from four different batches of a gilt development unit (GDU). On study day 0, batches 1 and 2 were exposed to M hyopneumoniae-positive lung homogenate via intratracheal (IT) route and were used as reference for batches 3 and 4, which were exposed using a mechanical fogger. Tracheobronchial swabs (TBS) were collected at 2 and 4 weeks post exposure (D14 and D28, respectively) and infection success was assessed by real-time polymerase chain reaction of pooled samples. In phase II, 1160 gilts from the same GDU belonging to three different batches (5 to 7) were exposed to M hyopneumoniae via NEB, and TBS were collected at D14. Results: In phase I, no statistically significant differences were observed between IT and NEB exposure in proportion of positives and mean cycle threshold values of TBS pooled samples at any time point (D14 and D28). In phase II, TBS pooled samples from all batches were positive for M hyopneumoniae at D14. Implications: Nebulization of lung homogenate positive for M hyopneumoniae resulted in infection of commercial gilts with this pathogen. Therefore, the use of NEB may be a reliable M hyopneumoniae exposure method under field conditions. The information generated in this investigation broadens the understanding of this technology as an acclimation strategy.
... It is generally acknowledged that in many herds the pigs are already infected during the periweaning period (Garza- Moreno et al., 2018). In these herds, the infection status of the sows around farrowing can be an important risk factor for colonization of their piglets . ...
... The levels of infection during the periweaning period have gained significant attention during the last years (Table 1). Transmission during this period is influenced by several overlapping factors, namely the type of production system , housing and management conditions inherent to each herd (Table 2) and also, the infection status of the breeding sow population (Stärk et al., 2000;Garza-Moreno et al., 2018). In age segregated systems with multi-site production, the sows are considered to be the reservoir of M. hyopneumoniae infections for the suckling and recently weaned piglets (Nathues et al., 2013a). ...
... In this context, there have been some efforts to utilize diagnostics in order to create a system which classifies the herds according to their infection status (Garza- Moreno et al., 2018). This system can be applied in gilt rearing sites, breeding herds, farrow-to-finish herds or only-fattening herds, whether or not these production facilities are part of single-site or multi-site production operations. ...
... On the other hand, M. hyopneumoniae negative herds and replacement gilts may have better reproductive performance and welfare because of the reduction of respiratory coinfections and use of antimicrobials . Regardless of the replacement gilts source, acclimation should be used to expose these animals to the agent, to create immunity in the gilt population, reduce herd health destabilization and exposure to the offspring (Takeuti et al. 2017b;Garza-Moreno et al. 2018). Different acclimation strategies can be used, such as vaccination alone or combined to natural (direct contact) or controlled (use of inoculum) exposure of gilts (Garza-Moreno et al., 2018). ...
... Regardless of the replacement gilts source, acclimation should be used to expose these animals to the agent, to create immunity in the gilt population, reduce herd health destabilization and exposure to the offspring (Takeuti et al. 2017b;Garza-Moreno et al. 2018). Different acclimation strategies can be used, such as vaccination alone or combined to natural (direct contact) or controlled (use of inoculum) exposure of gilts (Garza-Moreno et al., 2018). It is crucial that this management starts as early as possible to avoid positive and excreting sows at farrowing and lactation period . ...
... Exposure to M. hyopneumoniae during acclimation can be performed through natural or controlled exposure methods (Garza-Moreno et al. 2018). In natural exposure, the efficiency of transmission depends on the presence of shedding animals, which is difficult due to the low transmission rate (Meyns et al. 2004;Roos et al. 2016). ...
... The gilts of our study were not vaccinated against M. hyopneumoniae during the acclimation program to make interpretation of the serological results possible. This was a condition of our study, even though the benefits of M. hyopneumoniae vaccination during the acclimation period are known, including increasing immunity and decreasing the proportion of positive gilts 14 weeks post-infection (Garza-Moreno et al. 2018). The serological results showed that 100% of gilts exposed to the M. hyopneumoniae-positive inoculum were positive at 42 dpe. ...
Context Mycoplasma hyopneumoniae causes enzootic pneumonia, predisposing pigs to infections with other respiratory pathogens. The main control measure is to reduce piglet exposure at lactation, which can be achieved by gilts’ acclimation prior to their entrance to the farms. One of the acclimation strategies is aerosol exposure with a positive inoculum by using a fogger. However, studies on its efficacy in gilts and their litters are lacking in the literature. Aim The aim of this case study was to assess the efficacy fogging with a positive inoculum of M. hyopneumoniae to expose negative gilts in an acclimation program. Moreover, the infection dynamics of M. hyopneumoniae were assessed in their piglets from lactation to slaughter. Methods The trial was performed in two phases. In Phase 1, a total of 34 and 107 gilts was selected from Farms A and B respectively, and then exposed to the inoculum through a fogger. In Phase 2, a subsample of 74 gilts from Farm B was followed to their first farrowing and 263 piglets born to those gilts were sampled from 15 to 170 days of age, and at slaughter, lung lesions were evaluated. Key results In Phase 1, the prevalence of positive gilts at 28 days post-exposure (dpe) was 100% and 98.1% in Farms A and B respectively. In Phase 2, 10.8% of gilts remained positive at 180 dpe and 0.8% of piglets were positive at 15 days of age (day) and 28.1% at 60 days, suggesting a possible vertical transmission. Conclusion The use of fogging with a lung homogenate positive for M. hyopneumoniae successfully acclimated negative gilts. However, it did not avoid the presence of positive gilts at farrowing and the detection of the bacterium in their progeny by polymerase chain reaction. Implications The exposure of gilts to M. hyopneumoniae at 150 days of age was successfully achieved by fogging. However, consideration should be given to exposing replacement gilts of a younger age in order to reduce the odds of detecting positive gilts at first farrowing.
... The goal of M. hyopneumoniae vaccination is to raise pathogen-specific immune responses which respond fast and effectively upon a natural M. hyopneumoniae infection. Most commercially available M. hyopneumoniae vaccines for pigs are registered for administration between one and three weeks of age [4]. The onset of M. hyopneumoniae-specific immunity varies from one to four weeks and aims to protect against infections during the complete fattening period, until slaughter [4]. ...
... Most commercially available M. hyopneumoniae vaccines for pigs are registered for administration between one and three weeks of age [4]. The onset of M. hyopneumoniae-specific immunity varies from one to four weeks and aims to protect against infections during the complete fattening period, until slaughter [4]. ...
Mycoplasma hyopneumoniae is the primary agent of enzootic pneumonia in pigs. To minimize the economic losses caused by this disease, M. hyopneumoniae vaccination is commonly practiced. However, the persistence of M. hyo-pneumoniae vaccine-induced immunity, especially the cell-mediated immunity, till the moment of slaughter has not been investigated yet. Therefore, on two commercial farms, 25 pigs (n = 50) received a commercial bacterin intramus-cularly at 16 days of age. Each month, the presence of M. hyopneumoniae-specific serum antibodies was analyzed and the proliferation of and TNF-α, IFN-γ and IL-17A production by different T cell subsets in blood was assessed using recall assays. Natural infection with M. hyopneumoniae was assumed in both farms. However, the studied pigs remained M. hyopneumoniae negative for almost the entire trial. Seroconversion was not observed after vaccination and all pigs became seronegative at two months of age. The kinetics of the T cell subset frequencies was similar on both farms. Mycoplasma hyopneumoniae-specific cytokine-producing CD4 + CD8 + T cells were found in blood of pigs from both farms at one month of age but decreased significantly with increasing age. On the other hand, T cell proliferation after in vitro M. hyopneumoniae stimulation was observed until the end of the fattening period. Furthermore , differences in humoral and cell-mediated immune responses after M. hyopneumoniae vaccination were not seen between pigs with and without maternally derived antibodies. This study documents the long-term M. hyopneu-moniae vaccine-induced immune responses in fattening pigs under field conditions. Further research is warranted to investigate the influence of a natural infection on these responses.
... Vaccines play an important role to reduce the prevalence of EP (7,8). Among them, available inactivated vaccines, based mainly on J strain, do not provide complete protection against lung lesions (9,10). ...
... (B) Confirmation of the deleted genes by PCR. M, DNA marker 2,000; lanes 1,3, 5, 7, 9, 11, 13, 15, 17, and 19 correspond to genes E5E95_00935, E5E95_00940, E5E95_01845, E5E95_01850, E5E95_01855, E5E95_01860, E5E95_01905, E5E95_03755, E5E95_00670, and E5E95_00665 with strain ES-2 genome as a template, respectively.Lanes 2,4,6,8,10,12,14,16,18, and 20 indicate that these genes were amplified with strain ES-2L genome as template. ...
Mycoplasma hyopneumoniae causes swine respiratory disease worldwide. Due to the difficulty of isolating and cultivating M. hyopneumoniae, very few attenuated strains have been successfully isolated, which hampers the development of attenuated vaccines. In order to produce an attenuated M. hyopneumoniae strain, we used the highly virulent M. hyopneumoniae strain ES-2, which was serially passaged in vitro 200 times to produce the attenuated strain ES-2L, and its virulence was evidenced to be low in an animal experiment. In order to elucidate the mechanisms underlying virulence attenuation, we performed whole-genome sequencing of both strains and conducted comparative genomic analyses of strain ES-2 and its attenuated form ES-2L. Strain ES-2L showed three large fragment deletion regions including a total of 18 deleted genes, compared with strain ES-2. Analysis of single-nucleotide polymorphisms (SNPs) and indels indicated that 22 dels were located in 19 predicted coding sequences. In addition to these indels, 348 single-nucleotide variations (SNVs) were identified between strains ES-2L and ES-2. These SNVs mapped to 99 genes where they appeared to induce amino acid substitutions and translation stops. The deleted genes and SNVs may be associated with decreased virulence of strain ES-2L. Our work provides a foundation for further examining virulence factors of M. hyopneumoniae and for the development of attenuated vaccines.
... Therefore, the identification and characterization of the M. hyopneumoniae strains circulating within a herd or geographical region are of utmost importance. Discrimination among M. hyopneumoniae strains usually rely on partial sequencing of the P146 gene [45], multilocus sequence typing (MLST) [46], and multiple-locus variable number tandem repeat analysis (MLVA) [47][48][49]. More recently, Betlach et al. [49] reviewed published information on M. hyopneumoniae variability in pathogenicity and at the antigenic, proteomic, transcriptomic, and genomic levels, and proposed the variable number of tandem repeats (VNTR)-based common terminology and classification. ...
... Discrimination among M. hyopneumoniae strains usually rely on partial sequencing of the P146 gene [45], multilocus sequence typing (MLST) [46], and multiple-locus variable number tandem repeat analysis (MLVA) [47][48][49]. More recently, Betlach et al. [49] reviewed published information on M. hyopneumoniae variability in pathogenicity and at the antigenic, proteomic, transcriptomic, and genomic levels, and proposed the variable number of tandem repeats (VNTR)-based common terminology and classification. This VNTR-based system is expected to avoid discrepancies and allow to make inferences across the literature. ...
Mycoplasma hyopneumoniae: is the etiological agent of porcine enzootic pneumonia (EP), a disease that impacts the swine industry worldwide. Pathogen-induced damage, as well as the elicited host-response, contribute to disease. Here, we provide an overview of EP epidemiology, control and prevention, and a more in-depth review of M. hyopneumoniae pathogenicity determinants, highlighting some molecular mechanisms of pathogen-host interactions relevant for pathogenesis. Based on recent functional, immunological, and comparative “omics” results, we discuss the roles of many known or putative M. hyopneumoniae virulence factors, along with host molecules involved in EP. Moreover, the known molecular bases of pathogenicity mechanisms, including M. hyopneumoniae adhesion to host respiratory epithelium, protein secretion, cell damage, host microbicidal response and its modulation, and maintenance of M. hyopneumoniae homeostasis during infection are described. Recent findings regarding M. hyopneumoniae pathogenicity determinants also contribute to the development of novel diagnostic tests, vaccines, and treatments for EP.
... Control strategies for M. hyopneumoniae, including antimicrobials, vaccines and management practices, have been employed to reduce the economic losses derived from the clinical manifestations of EP (Garza-Moreno, Segalés, Pieters, Romagosa, & Sibila, 2018;Maes et al., 2018;Pieters & Fano, 2016). ...
... Factorscontributing to adherence and colonization, as well as the capacity to modulate the inflammatory and immune response might play a role.Meyns et al. (2007) showed that the difference between the highly and low virulent isolates was associated with a faster in vitro growth, a higher capacity to multiply in the lungs and the induction of a more severe inflammation process (e.g. higher TNF-alpha and IL-1β concentration in BAL fluid) by the highly virulent isolate.Woolley et al. (2012) also detected significantly higher levels of IL-1β and IL-6 in BAL fluid in pigs challenged with a highly virulent strain.A faster in vitro multiplication of a highly virulent isolate during the logarithmic phase was confirmed byCalus et al. (2010), suggesting a higher capacity to multiply in the lungs. In contrast,Garza-Moreno et al. (2018) described the fastest growing strain to be M. hyopneumoniae strain J using colour changing units.Villarreal et al. (2011) demonstrated that contrary to a highly virulent strain, a low virulent strain required more than 4 weeks post-infection to reach maximum infection levels and clinical signs.Different components of the cell membrane (i.e. proteins, glycoproteins and lipoproteins) may serve as adhesins and/or be toxic for the respiratory tract cells. ...
Mycoplasma hyopneumoniae (M. hyopneumoniae) is the etiologic agent of enzootic pneumonia in swine, a prevalent chronic respiratory disease worldwide. Mycoplasma hyopneumoniae is a small, self‐replicating microorganism that possesses several characteristics allowing for limited biosynthetic abilities, resulting in the fastidious, host‐specific growth, and unique pathogenic properties of this microorganism. Variation across several isolates of M. hyopneumoniae has been described at antigenic, proteomic, transcriptomic, pathogenic, and genomic levels. The microorganism possesses a minimal number of genes that regulate the transcription process. Post‐translational modifications (PTM) occur frequently in a wide range of functional proteins. The PTM by which M. hyopneumoniae regulates its surface topography could play key roles in cell adhesion, evasion, and/or modulation of the host immune system.
The clinical outcome of M. hyopneumoniae infections is determined by different factors, such as housing conditions, management practices, co‐infections, and also by virulence differences among M. hyopneumoniae isolates. Factors contributing to adherence and colonization as well as the capacity to modulate the inflammatory and immune responses might be crucial.
Different components of the cell membrane (i.e. proteins, glycoproteins and lipoproteins) may serve as adhesins and/or be toxic for the respiratory tract cells. Mechanisms leading to virulence are complex and more research is needed to identify markers for virulence.
The utilization of typing methods, and complete or partial‐gene sequencing for M. hyopneumoniae characterization has increased in diagnostic laboratories as control and elimination strategies for this microorganism are attempted worldwide. A commonly employed molecular typing method for M. hyopneumoniae is Multiple‐Locus Variable number tandem repeat Analysis (MLVA). The agreement of a shared terminology and classification for the various techniques, specifically MLVA, has not been described, which makes inferences across the literature not suitable. Therefore, molecular trends for M. hyopneumoniae have been outlined and a common terminology and classification based on VNTR types has been proposed.
This article is protected by copyright. All rights reserved.
... Moreover, a key managemental practice among this age group is acclimatization of replacement gilts on introduction into a breeding farm. This involves, among many practices, exposure of replacement gilts to fresh fecal and placental material from older breeding sows as a means of inducing immunity against endemic pathogens on the receiving farm [45,46]. ...
Background
Exploring the microbiome in multiple body sites of a livestock species informs approaches to promote its health and performance through efficient and sustainable modulation of these microbial ecosystems. Here, we employed 16S rRNA gene sequencing to describe the microbiome in the oropharyngeal cavity, proximal colon, and vaginal tract of Jeju Black pigs (JBP), which are native to the Korean peninsula.
Results
We sampled nine 7-month-old JBP gilts raised under controlled conditions. The most abundant phyla that we found within the oropharyngeal microbiota were Proteobacteria , Bacteroidetes , Fusobacteria and Firmicutes, collectively providing core features from twenty-five of their genera. We also found a proximal colonic microbial core composed of features from twenty of the genera of the two predominant phyla, Firmicutes , and Bacteroidetes . Remarkably, within the JBP vaginal microbiota, Bacteroidetes dominated at phylum level, contrary to previous reports regarding other pig breeds. Features of the JBP core vaginal microbiota, came from seventeen genera of the major phyla Bacteroidetes , Firmicutes , Proteobacteria , and Fusobacteria. Although these communities were distinct, we found some commonalities amongst them. Features from the genera Streptococcus , Prevotella , Bacillus and an unclassified genus of the family Ruminococcaceae were ubiquitous across the three body sites. Comparing oropharyngeal and proximal colonic communities, we found additional shared features from the genus Anaerorhabdus . Between oropharyngeal and vaginal ecosystems, we found other shared features from the genus Campylobacter , as well as unclassified genera from the families Fusobacteriaceae and Flavobacteriaceae . Proximal colonic and vaginal microbiota also shared features from the genera Clostridium , Lactobacillus, and an unclassified genus of Clostridiales .
Conclusions
Our results delineate unique and ubiquitous features within and across the oropharyngeal, proximal colonic and vaginal microbial communities in this Korean native breed of pigs. These findings provide a reference for future microbiome-focused studies and suggest a potential for modulating these communities, utilizing ubiquitous features, to enhance health and performance of the JBP.
... However, Deffner and colleagues found that only 31.3 per cent of the sampled farms vaccinated their sows against M hyopneumoniae, which is much lower than the 58 per cent reported previously. 24 Interestingly, farms that vaccinated their sows against M hyopneumoniae had a lower rate of positivity in finishing pigs compared to farms where no sow vaccination was applied. 17 Experimental work by Meyns and colleagues 25 has previously demonstrated a clear reduction in pathogen spread in vaccinated piglets compared with unvaccinated piglets (R n -value of 2.38 and 3.51, respectively). ...
... Vaccination of gilts against M. hyopneumoniae was practiced on all farms except one. It is recommended to vaccinate gilts against M. hyopneumoniae to reduce shedding and transmission, but vaccination will not prevent infection [15,[28][29][30]. This is supported by our data, as despite gilt vaccination the number of M. hyopneumoniae infected animals on a farm can be high. ...
Background
Dam-to-piglet transmission plays an important role in the epidemiology of enzootic pneumonia on farms. Although Mycoplasma hyopneumoniae ( M. hyopneumoniae ) infections in breeding animals are often subclinical, their control could have a positive effect on M. hyopneumoniae infection levels in fattening pigs. This study investigated the presence of M. hyopneumoniae in the breeding population of ten Belgian farrow-to-finish farms suspected by the herd veterinarian to be M. hyopneumoniae infected. Gilt vaccination against M. hyopneumoniae prior to first insemination was practiced on nine of the ten farms. At four different time points in the reproductive cycle 20 animals were sampled on each farm, namely 30–40 days of gestation, 75–85 days of gestation, 3–5 days after farrowing, and 1–3 days after weaning. In total, tracheobronchial swabs and blood samples were collected from 344 gilts and 456 sows (n = 80/farm). Swabs were analysed for the presence of M. hyopneumoniae DNA using nested PCR and M. hyopneumoniae -specific antibodies were detected in serum with a commercial ELISA. Generalized linear mixed models with farm as random factor were used to test the effect of time point in the reproductive cycle and parity on M. hyopneumoniae PCR prevalence and seroprevalence.
Results
M. hyopneumoniae PCR prevalence ranged between 0% and 43.8% at the farm level and the seroprevalence between 32.5% and 93.8%. Gilts were significantly more M. hyopneumoniae PCR positive than sows at the 2-4th parity (P = 0.02) and > 4th parity (P = 0.02). At 30–40 days of gestation, significantly more breeding animals were PCR positive as compared to 75–85 days of gestation (P = 0.04), 3–5 days after farrowing (P = 0.02) and 1–3 days after weaning (P = 0.02). Gilts had significantly more often M. hyopneumoniae -specific antibodies than sows (P = 0.03).
Conclusions
M. hyopneumoniae PCR prevalence varied a lot between farms and due to gilt vaccination the number of animals with M. hyopneumoniae -specific antibodies was high on most farms. Gilts were more often M. hyopneumoniae PCR positive than sows and positive animals were mostly found at 30–40 days of gestation. This emphasizes the importance of a sufficiently long quarantine period and proper gilt acclimation practices before introducing gilts to the sow herd.
... PEP is a widespread chronic respiratory disease of swine that is characterized by coughing, reduced weight gain, and decreased feed conversion [1]. M. hyopneumoniae infection is restricted to the lung [2] and exhibits high morbidity and low mortality [1]; however, PEP continues to have a substantial economic impact on the swine industry, worldwide [3]. Some studies have reported that M. hyopneumoniae infection increases the susceptibility of swine to secondary infection, causing porcine respiratory disease complex (PRDC) [1,4]. ...
Background
Immunization of pigs with an inactivated Mycoplasma hyopneumoniae vaccine (bacterin) generates hyperimmune serum that contains high concentrations of anti-M. hyopneumoniae IgG. Commercially available IgG-ELISA kits cannot distinguish between anti-M. hyopneumoniae IgG in inactivated bacterin-induced hyperimmune sera and convalescent sera resulting from natural M. hyopneumoniae infection. Establishment of an ELISA to detect anti-M. hyopneumoniae IgG in convalescent sera will facilitate the evaluation of the M. hyopneumoniae status of pig farms.
Results
In this study, we expressed and purified recombinant Mhp366-N protein, which contains an epitope recognized by M. hyopneumoniae convalescent sera but not hyperimmune sera, for use as a coating antigen. For the M. hyopneumoniae convalescent serum IgG-ELISA, the optimal antigen concentration, blocking buffer, blocking time, dilution of serum, incubation time with serum, secondary antibody dilution, secondary antibody incubation time and colorimetric reaction time were 0.25 µg/mL, 2.5 % skim milk, 1 h, 1:500, 0.5 h, 1:10,000, 1 h and 15 min, respectively. Validation of the M. hyopneumoniae convalescent serum IgG-ELISA showed a cut-off value of 0.323, the intra-assay CV ranged from 3.27 to 7.26 %, the inter-assay CV ranged from 3.46 to 5.93 %, and the assay was able to differentiate convalescent sera from antibodies to 7 other porcine respiratory pathogens. The convalescent serum IgG-ELISA detected no anti-M. hyopneumoniae IgG in hyperimmune serum samples while a commercial IgG-ELISA identified 95/145 of these sera as positive. The accuracy of the M. hyopneumoniae convalescent serum IgG-ELISA was comparable to the sIgA-ELISA but better than the commercial IgG-ELISA.
Conclusions
The convalescent serum IgG-ELISA is a reproducible, sensitive, and specific indirect ELISA to detect anti-M. hyopneumoniae IgG in naturally infected pathogen-induced convalescent sera. This ELISA could be used to carry out large scale surveillance of M. hyopneumoniae infection in pig farms regardless of vaccination status.
... In the North American swine industry it is common to house breeding gilts in a specialised gilt development unit (GDU). GDUs are used to raise gilts and to gradually adapt them to the health status of the sow herd [24]. ...
Background
The breeding population is very important in pig herds, for productivity, health and profitability. Replacement of breeding animals can be accomplished by own rearing of breeding gilts or by purchasing them. Purchasing breeding gilts is a hazardous event in terms of biosecurity and introduction of pathogens into a farm. However, in literature, little is known about gilt introduction in a herd. The present study investigated the introduction procedures of purchased breeding gilts in Belgian pig herds, and the compliance of these herds to the optimal introduction procedures. A questionnaire consisting of twenty questions related to farm characteristics ( n = 2), purchasing policy ( n = 6), quarantine period ( n = 5), and acclimation practices ( n = 7) was designed, and 68 farms completed the questionnaire during an on-farm interview.
Results
The median (min. – max.) number of sows on the farms was 300 (85–2500). Fifty-seven per cent of the farms purchased breeding gilts, and there was a lot of variation in the frequency of purchase and the age at which gilts are purchased. On 95 % of those farms, a quarantine unit was used, and on most of these farms the quarantine was located on the farm itself (internal quarantine). The median (min. – max.) duration of the quarantine period was 42 (14–140) days. The most common acclimation practice was vaccination against Porcine parvovirus (96 %) and Erysipelothrix rhusiopathiae (94 %), although in some farms exposure of gilts to farm-specific micro-organisms was done by providing faeces from suckling piglets (18 %) and bringing gilts in contact with sows that will be culled (16 %). Only 10 % of the farms complied with the optimal introduction procedures, i.e. purchasing policy, quarantine building and quarantine management.
Conclusions
This study showed that in many farms, practices related to purchasing, quarantine and acclimation could be improved to maintain optimal biosecurity.
... A combination was observed between M. hyopneumoniae and PRRSV or S. suis (36,37). Different studies have demonstrated that disease severity in growing pigs is correlated with several factors (38,39). The fact that M. hyopneumoniae was frequently found in organs without lesions corroborates the finding that it is a common pathogen with effects that are likely dependent on other triggering factors, however we cannot exclude that M. hyopneumoniae has been detected in the first stage of the infection. ...
Porcine Respiratory Disease Complex (PRDC) is a multifactorial syndrome that causes health problems in growing pigs and economic losses to farmers. The etiological factors involved can be bacteria, viruses, or mycoplasmas. However, environmental stressors associated with farm management can influence the status of the animal's health. The role and impact of different microorganisms in the development of the disease can be complex, and these are not fully understood. The severity of lesions are a consequence of synergism and combination of different factors. The aim of this study was to systematically analyse samples, conferred to the Veterinary Diagnostic Laboratory (IZSLER, Brescia), with a standardized diagnostic protocol in case of suspected PRDC. During necropsy, the lungs and carcasses were analyzed to determine the severity and extension of lesions. Gross lung lesions were classified according to a pre-established scheme adapted from literature. Furthermore, pulmonary, pleural, and nasal lesions were scored to determine their severity and extension. Finally, the presence of infectious agents was investigated to identify the microorganisms involved in the cases studied. During the years 2014–2016, 1,658 samples of lungs and carcasses with PRDC from 863 farms were analyzed; among them 931 and 727 samples were from weaned piglets and fattening pigs, respectively. The most frequently observed lesions were characteristic of catarrhal bronchopneumonia, broncho-interstitial pneumonia, pleuropneumonia, and pleuritis. Some pathogens identified were correlated to specific lesions, whereas other pathogens to various lesions. These underline the need for the establishment of control and treatment programmes for individual farms.
... The most common practice to prevent Mhyo infections is vaccination [9]. In fact, there is a high number of vaccine products marketed worldwide [9,10], which are mainly applied from the first week of life onwards. Infection due to PCV-2 is almost uniquely prevented and controlled by means of vaccination, being applied mostly around weaning [11]. ...
Background:
Mycoplasma hyopneumoniae (Mhyo) and Porcine circovirus 2 (PCV-2) are two of the most significant infectious agents causing economic losses in the weaning to slaughter period. Due to their similar vaccination age, the objective of this study was to assess the efficacy of two already existing Mhyo (Hyogen®) and PCV-2 (Circovac®) vaccines when administered separately or combined (RTM) by means of Mhyo or PCV-2 experimental challenges.
Results:
Seven groups of animals were included in the study, being three of them challenged with PCV-2, three with Mhyo and one composed of non-challenged, non-vaccinated pigs. Within each experimental challenge, non-vaccinated (NV) groups were compared with double vaccinated groups using the commercial products separated (VS) or combined (VC). Both vaccinated groups showed significant differences for most parameters measured regarding PCV-2 (serology, percentage of infected animals and viral load in tissues) and Mhyo (serology and gross lesions) when compared to NV groups. VS and VC offered similar results, being only significantly different the PCV-2 antibody values at different time points (higher in the VS group) of the study, although not at the termination day (21 days post-PCV-2 inoculation).
Conclusion:
The present study expands the knowledge on the possibility of using two separate Mhyo and PCV-2 commercial vaccines as a RTM product, which offered equivalent virological, immunological and pathological outcomes as compared to these vaccines when used by separate.
... Similarly, gilts that have been infected by IAV before or during the acclimatization period will have time to recover from the infection before transfer to the barn. Such practices have been pointed out as an efficient controlling measure for PRRS virus (Dee et al., 1995) and Mycoplasma hyopneumoniae (Garza-Moreno et al., 2018;Nathues et al., 2014). Failure to apply the acclimatization practice, enhanced by a high frequency of introduction of animals from different origins, seems to be an important opportunity for influenza virus to enter into the studied herds. ...
Cocktail vaccines are proposed as an attractive way to increase protection efficacy against specific tick species. Furthermore, such vaccines made with different tick antigens have the potential of cross-protecting against a broad range of tick species. However, there are still limitations to the selection of immunogen candidates. Acknowledging that glutathione S-transferases (GSTs) have been exploited as vaccines against ticks and other parasites, this study aimed to analyze a GST-cocktail vaccine as a potential broad-spectrum tick vaccine. To constitute the GST-cocktail vaccine, five tick species of economic importance for livestock industry were studied (Rhipicephalus appendiculatus, Rhipicephalus decoloratus, Rhipicephalus microplus, Amblyomma variegatum, and Haemaphysalis longicornis). Tick GST ORF sequences were cloned, and the recombinant GSTs were produced in Escherichia coli. rGSTs were purified and inoculated into rabbits, and the immunological response was characterized. The humoral response against rGST-Rd and rGST-Av showed a stronger cross-reactivity against heterologous rGSTs compared to rGST-Hl, rGST-Ra, and rGST-Rm. Therefore, rGST-Rd and rGST-Av were selected for constituting an experimental rGST-cocktail vaccine. Vaccination experiment in rabbits showed that rGST-cocktail caused 35% reduction in female numbers in a Rhipicephalus sanguineus infestation. This study brings forward an approach to selecting immunogens for cocktail vaccines, and the results highlight rGST-Rd and rGST-Av as potentially useful tools for the development of a broad-spectrum tick vaccine.
... Similarly, gilts that have been infected by IAV before or during the acclimatization period will have time to recover from the infection before transfer to the barn. Such practices have been pointed out as an efficient controlling measure for PRRS virus (Dee et al., 1995) and Mycoplasma hyopneumoniae (Garza-Moreno et al., 2018;Nathues et al., 2014). Failure to apply the acclimatization practice, enhanced by a high frequency of introduction of animals from different origins, seems to be an important opportunity for influenza virus to enter into the studied herds. ...
... Therefore, an adequate gilt acclimation program should focus on reduction of M. hyopneumoniae shedding at first farrowing (Garza-Moreno et al., 2016). In Europe and North-America, vaccination of replacement gilts is the main tool for gilt acclimation, however, there is a trend in the US nowadays of deliberately exposing the gilts to the pathogen (Garza-Moreno et al., 2018). It was already demonstrated that the absence of gilt acclimation by providing the replacement stock access to other living animals was addressed being a risk factor for M. hyopneumoniae disease severity in fattening pigs (Garza-Moreno et al., 2016;Nathues et al., 2016). ...
Respiratory diseases cause significant issues in pigs worldwide. Welfare concerns, disease burden, decreased production, and low worker morale can all be effects of swine respiratory diseases. Various infectious and noninfectious agents, alone or in combination, can induce or predispose to respiratory disease in pigs. Viruses and bacteria are the main types of infectious agents affecting the respiratory tract of pigs. Infections of polymicrobial origin are usually termed porcine respiratory disease complex and group disease manifestations of multiviral, multibacterial, or mixed nature. In this chapter, the main diseases affecting the respiratory tract of pigs are briefly described, making emphasis on the basics of etiology, epidemiology, clinical presentation, lesions, treatment, and control for each agent. Viruses such as porcine circovirus type 2, porcine reproductive and respiratory syndrome virus, and influenza A virus and bacteria, namely, Mycoplasma hyopneumoniae, Actinobacillus pleuropneumoniae, Pasteurella multocida, and Bordetella bronchiseptica, are depicted given their importance in swine health. Other infectious agents and factors potentially affecting the respiratory system of pigs are listed, and readers are encouraged to dig deeper into the understanding of the processes that drive the lack of health of this important body system.
Tracheal pooling for Mycoplasma hyopneumoniae (M. hyopneumoniae) DNA detection allows for decreased diagnostic cost, one of the main constraints in surveillance programs. The objectives of this study were to estimate the sensitivity of pooled-sample testing for the detection of M. hyopneumoniae in tracheal samples and to develop probability of M. hyopneumoniae detection estimates for tracheal samples pooled by 3, 5, and 10. A total of 48 M. hyopneumoniae PCR-positive field samples were pooled 3-, 5-, and 10-times using field M. hyopneumoniae DNA-negative samples and tested in triplicate. The sensitivity was estimated at 0.96 (95% credible interval [Cred. Int.]: 0.93, 0.98) for pools of 3, 0.95 (95% Cred. Int: 0.92, 0.98) for pools of 5, and 0.93 (95% Cred. Int.: 0.89, 0.96) for pools of 10. All pool sizes resulted in PCR-positive if the individual tracheal sample Ct value was < 33. Additionally, there was no significant decrease in the probability of detecting at least one M. hyopneumoniae-infected pig given any pool size (3, 5, or 10) of tracheal swabs. Furthermore, this manuscript applies the probability of detection estimates to various real-life diagnostic testing scenarios. Combining increased total animals sampled with pooling can be a cost-effective tool to maximize the performance of M. hyopneumoniae surveillance programs.
Ante- and post-mortem inspections of food-producing animals at slaughter are mandatory activities carried out in many countries to ensure public health, animal health, and meat quality. In finishing pigs, lung lesions are the most frequent defects found in meat inspections. It is possible to implement managerial strategies on-farm to reduce the occurrence and spread of respiratory diseases, but such strategies come with additional costs that could impede implementation. This study assessed the economic impact of two strategies aimed at reducing the prevalence of lung lesions in finishing pigs at slaughter by improving the health conditions of the animals during the production cycle. First, a farrow-to-finish pig farm with 355 sows was modeled based on the current standard practice for finishing pig production in Sweden, using economic data, meat inspection data and biological variables from the literature and expert opinions. A partial budget analysis was then performed in which the baseline farm was compared with two hypothetical strategies aimed at reducing the occurrence and spread of respiratory diseases during pig production: (S1) avoiding mixing of litters after weaning and (S2) keeping purchased pregnant gilts separated from sows during gestation, farrowing and lactation. Both these strategies intended to reduce the occurrence of respiratory disease in finishing pigs at slaughter gave an average gain in annual net income (33,805 SEK in S1 and 173,160 SEK in S2, equal to 3,146€ and 16,113€, respectively, at the time of analysis), indicating that both were economically sustainable under the assumed conditions. The impact analysis of the two strategies revealed that the reduced prevalence of lung lesions when adopting one of the strategies was the most influential factor in net benefit change on the farm. Overall, the results suggest that with the increasing prevalence of lung lesions in Swedish pig production (as also observed worldwide in recent years), adopting an effective strategy to decrease respiratory infections will become more relevant and economically beneficial.
Mycoplasma hyopneumoniae remains one of the most problematic bacterial pathogens for pig production. Despite an abundance of observational and laboratory testing capabilities for this organism, diagnostic interpretation of test results can be challenging and ambiguous. This is partly explained by the chronic nature of M. hyopneumoniae infection and its tropism for lower respiratory tract epithelium, which affects diagnostic sensitivities associated with sampling location and stage of infection. A thorough knowledge of the available tools for routine M. hyopneumoniae diagnostic testing, together with a detailed understanding of infection dynamics, are essential for optimizing sampling strategies and providing confidence in the diagnostic process. This study reviewed known information on sampling and diagnostic tools for M. hyopneumoniae and summarized literature reports of the dynamics of key infection outcomes, including clinical signs, lung lesions, pathogen detection, and humoral immune responses. Such knowledge could facilitate better understanding of the performance of different diagnostic approaches at various stages of infection.
Mycoplasma hyopneumoniae (M. hyopneumoniae) infections continue to result in significant respiratory challenges in the swine industry worldwide. Vaccination for M. hyopneumoniae is commonly utilized, as reduction in bacterial loads and clinical severity in vaccinated pigs have been shown. However, the effect of M. hyopneumoniae vaccination on transmission across different pig populations has been minimally investigated. The aim of this pilot study was to evaluate the effect of multiple vaccinations on M. hyopneumoniae infection, transmission, and genetic variability in infected and susceptible gilt populations. Thirty-two naïve gilts were allocated to four treatment groups: (1) Vaccinated seeder (VS); (2) Non-vaccinated seeder (NVS); (3) Vaccinated contact (VC); and (4) Non-vaccinated contact (NVC). At 5, 7, and 9 weeks of age, all gilts selected to be vaccinated received a commercial M. hyopneumoniae bacterin for a total of 3 doses. At 11 weeks of age, VS and NVS gilts were inoculated with M. hyopneumoniae to become seeders. At 28 days post-inoculation (dpi), VS and NVS gilts were individually relocated to clean experimental rooms, where they were placed in contact with one age-matched VC or NVC gilt (1:1 ratio) for 14 days. Blood and tracheal samples, bronchial swabs, and lung lesions were collected and/or evaluated for M. hyopneumoniae infection. In this study, a three-dose vaccination strategy against M. hyopneumoniae significantly reduced bacterial load in seeder gilts. Furthermore, a numerical reduction in M. hyopneumoniae lung lesions at 28 dpi was observed in VS gilts. All VC gilts in the VS:VC treatment group pairing remained M. hyopneumoniae negative, compared to other groups in which 1–2 transmission events occurred per treatment group. Results from this investigation provide insight on the potential impact of multiple vaccinations on reducing M. hyopneumoniae transmission and infection. Further research encompassing vaccinations of gilt groups in field settings is necessary to validate findings.
Mycoplasma hyopneumoniae ( M. hyopneumoniae ) causes the disease porcine enzootic pneumonia, a highly contagious and chronic disease affecting pigs. Understanding the molecular mechanisms of its pathogenicity is critical for developing effective interventions to control this swine respiratory disease. Here, we describe a novel virulence mechanism, by which M. hyopneumoniae interferes with the host unfolded protein response (UPR) and eventually facilitates bacterial adhesion and infection. We observed that M. hyopneumoniae infection suppressed the UPR target molecules GRP78 and CHOP by reducing PERK/eIF2α phosphorylation, ATF6 cleavage and XBP1 splicing. Interestingly, further analyses revealed that host UPR inhibition subsequently suppressed the NF-κB pathway, leading to the reduced production of porcine beta-defensin 2 (PBD-2), thus facilitating M. hyopneumoniae adherence and infection. This study provides new insights into the molecular pathogenesis of M. hyopneumoniae and sheds light upon their interactions with the host.
Background:
Porcine circovirus and Mycoplasma hyopneumoniae can cause respiratory diseases in pigs, which cause serious economic loss in the worldwide pig industry. Currently, these infections are mainly prevented and controlled by vaccination. The new vaccines on the market are mainly composed of subunits and inactivated vaccines but usually have lower antigenicity than traditional live vaccines. Thus, there is an increasing need to develop new adjuvants that can cause rapid and long-lasting immunity to enhance the antigenic efficacy for vaccines. Studies have shown that meningococcal porin PorB can act as a ligand to combine with Toll-like receptors to activate the production of immunological projections and act as a vaccine immunological adjuvant.
Objective:
In this article, we expressed and purified the recombinant PorB protein and verified its immunogenicity against porcine circovirus type 2 and Mycoplasma hyopneumoniae genetically engineered vaccine.
Methods:
In this article, we used prokaryotic expression to express and purify recombinant PorB protein, four different concentrations of PorB protein, Freund's adjuvant with two genetically engineered vaccines were combined with subcutaneous immunization of mice.
Results:
Our study shows that the appropriate dose of the recombinant protein PorB can enhance the levels of humoral and cellular responses induced by two genetically engineered vaccines in a short period of time in mice. The PorB adjuvant group may cause statistically higher antibody titers for both genetically engineered vaccines compared to Freund's commercial adjuvant (P<0.001).
Conclusion:
The recombinant protein PorB may be a good candidate adjuvant for improving the protective effect of vaccines against porcine circovirus type 2 and Mycoplasma hyopneumoniae, and the protein can be used for future practical applications.
Gilts are considered to play a key role in Mycoplasma hyopneumoniae (M. hyopneumoniae) transmission and control. An effective gilt acclimation program should ideally reduce M. hyopneumoniae shedding at first farrowing, decreasing pre-weaning colonization prevalence and potential respiratory problems in fatteners. However, information on gilt acclimation practices is scarce in Europe. The aim of this study was to identify current acclimation strategies for M. hyopneumoniae in Europe using a questionnaire designed to assess 15 questions focused on gilt replacement status, acclimation strategies and methods used to ascertain its effect. A total of 321 questionnaires (representing 321 farms) were voluntarily completed by 108 veterinarians (from 18 European countries). From these farms, 280 out of 321 (87.2%) were aware of the health status of gilts on arrival. From these 280 farms, 161 (57.5%) introduced M. hyopneumoniae positive replacements. In addition, 249 out of 321 (77.6%) farms applied an acclimation process using different strategies, being M. hyopneumoniae vaccination (145 out of 249, 58.2%) and the combination of vaccine and exposure to sows selected for slaughter (53 out of 249, 21.3%) the most commonly used. Notwithstanding, only 53 out of 224 (23.6%) farms, knowing the M. hyopneumoniae initial status and performing acclimation strategies against it, verified the effect of the acclimation by ELISA (22 out of 53, 41.5%), PCR (4 out of 53, 7.5%) or both (27 out of 53, 50.9%). This study showed that three fourths of the farms represented in this European survey have M. hyopneumoniae acclimation strategies for gilts, and one fifth of them verify to some extent the effect of the process. Taking into account that the assessment of acclimation efficacy could help in optimizing replacement gilt introduction into the breeding herd, it seems these practices for M. hyopneumoniae are still poorly developed in Europe.
This study assessed the efficacy of two different Mycoplasma hyopneumoniae vaccination programmes in relation to the time of weaning. Eight hundred and twenty-eight piglets were randomly divided into three groups: group V1 was vaccinated three days before weaning, group V2 at weaning (21 days of age) and group NV was left non-vaccinated. Vaccinations were performed using Ingelvac MycoFLEX. After the nursery period, 306 pigs were allocated to fattening unit (F1) and 501 pigs to a second unit (F2). Efficacy was evaluated using performance parameters and pneumonia lesions at slaughter. Statistically significant differences were obtained in F2 where group V1 had a higher average daily weight gain compared to groups V2 and NV for the entire study period (17 and 18 g/day, respectively) and the fattening period (26 and 36 g/day, respectively) (P<0.05). Considering respiratory disease scores for both fattening units, group V1 was the only group where coughing severity did not increase significantly between placement and the end of the fattening period (P>0.05). Between groups, there were no statistically significant differences for the average lung lesion scores (V1=3.44; V2=4.61; NV=4.55, P>0.05) and the prevalence of pneumonia (V1=35.0 per cent; V2=38.0 per cent; NV=41.4 per cent, P>0.05). Overall, vaccination against M hyopneumoniae before weaning provided numerically better performance than vaccination at weaning, but did not reach statistical significance. An influenza outbreak in F1 and the presence of coexisting mixed respiratory infections in both F1 and F2 could have possibly influenced the performance of both vaccinated groups across all measured parameters.
The importance of diversity of Mycoplasma hyopneumoniae (M. hyopneumoniae) strains is not yet fully known. This study investigated the genetic diversity of M. hyopneumoniae strains in ten pig herds, and assessed associations between the presence of different strains of M. hyopneumoniae and lung lesions at slaughter. Within each herd, three batches of slaughter pigs were investigated. At slaughter, from each batch, 20 post mortem bronchoalveolar lavage fluid samples were collected for multiple locus variable-number tandem repeat analysis (MLVA), and lung lesions (Mycoplasma-like lesions, fissures) were examined. Multivariable analyses including potential risk factors for respiratory disease were performed to assess associations between the number of different strains per batch (three categories: one strain, two–six strains, ≥seven strains), and the lung lesions as outcome variables. In total, 135 different M. hyopneumoniae strains were found. The mean (min.–max.) number of different strains per batch were 7 (1–13). Batches with two–six strains or more than six strains had more severe Mycoplasma-like lesions (P = 0.064 and P = 0.012, respectively), a higher prevalence of pneumonia [odds ratio (OR): 1.30, P = 0.33 and OR: 2.08, P = 0.012, respectively], and fissures (OR = 1.35, P = 0.094 and OR = 1.70, P = 0.007, respectively) compared to batches with only one strain. In conclusion, many different M. hyopneumoniae strains were found, and batches of slaughter pigs with different M. hyopneumoniae strains had a higher prevalence and severity of Mycoplasma-like lung lesions at slaughter, implying that reducing the number of different strains may lead to less lung lesions at slaughter and better respiratory health of the pigs.
Commercial bacterins are widely used at weaning to control Mycoplasma hyopneumoniae infections in pigs. However, it is not known whether the efficacy of vaccinating against M. hyopneumoniae can be influenced by the weaning process when vaccination is applied at the day of weaning. The present study assessed the efficacy of a single M. hyopneumoniae vaccination (Ingelvac MycoFLEX®) three days before weaning (V1) or at weaning (V2) against experimental challenge infection. Four weeks after vaccination, groups V1 and V2 (n = 20 pigs each) and a non-vaccinated, positive control group (PCG) (n = 20) were endotracheally inoculated with a virulent M. hyopneumoniae field strain. Five pigs were used as a negative control group. All pigs were euthanized 5 weeks after challenge. The main parameters investigated included macroscopic and histopathological lung lesions at necropsy, immunofluorescence (IF) staining and quantitative real-time PCR (qPCR) on broncho-alveolar lavage (BAL) fluid for quantifying M. hyopneumoniae.
The average macroscopic lung lesion scores in groups V1, V2 and PCG were 0.54, 0.88 and 1.04, respectively (P > 0.05). The average lymphohistiocytic infiltration scores in groups V1, V2 and PCG were 2.95, 3.16 and 3.61, respectively (P < 0.05). The average IF scores were: V1 = 1.13, V2 = 1.19 and PCG = 1.25 (P > 0.05), the qPCR values were: V1 = 10 2.94 , V2 = 10 2.76 and PCG = 10 3.23 (P > 0.05). All pigs of the negative control group remained negative throughout the study.
Both vaccinated groups had lower numbers of macroscopic and histopathological lung lesions, and lower numbers of M. hyopneumoniae organisms in the BAL fluid compared to the PCG. However, no firm conclusions could be made on whether weaning negatively influences the efficacy of M. hyopneumoniae vaccination, since significant differences between the treatment groups were only obtained for the histopathological lung lesions. This could be attributed to the fact that milder macroscopic lung lesions were produced in the inoculated pigs, when compared to previous trials conducted by the same group. Further research under field conditions is warranted to assess possible differences between the two vaccination strategies.
The aim of this study was to determine the prevalence of M. hyopneumoniae infection in suckling pigs. Nasal swabs were collected from 300 suckling pigs originating from five farrow-to-finishing farms. One farm had a confirmed PRDC problem (farm A) and four other farms previously had a PRDC problem (farms B, C, D and E). Thirty (30) lac-tating sows in parity 1, 2 and 3 were selected from each farm (Ten sows per parity). Two piglets from each sow were randomly sampled for nasal swab at 3 weeks of age. The samples were analyzed by the nested PCR technique. Forty five per cent (27/60) of nasal swabs from farm A were found positive. On the other hand, a total of 2.08 per cent were found positive (5/240) from farm B, C, D and E. The tendency of piglet infection per sow by parity showed that first parity had more prevalence than the second and the third parity (60%, 55%, 20%), respectively. We have found a cor-rection between M. hyopneumoniae early infection in suckling pigs and a confirmed PRDC problem (farm A) as oppose to farms that did not have a PRDC problem. The strategies to prevent M. hyopneumoniae early infection are to maintain good lactation, antibiotic prevention program and early M. hyopneumoniae vaccination.
Antibiotic resistance can be reduced by using antibiotics prudently based on guidelines of antimicrobial stewardship programs (ASPs) and various data such as pharmacokinetic (PK) and pharmacodynamic (PD) properties of antibiotics, diagnostic testing, antimicrobial susceptibility testing (AST), clinical response, and effects on the microbiota, as well as by new antibiotic developments. The controlled use of antibiotics in food animals is another cornerstone among efforts to reduce antibiotic resistance. All major resistance-control strategies recommend education for patients, children (e.g., through schools and day care), the public, and relevant healthcare professionals (e.g., primary-care physicians, pharmacists, and medical students) regarding unique features of bacterial infections and antibiotics, prudent antibiotic prescribing as a positive construct, and personal hygiene (e.g., handwashing). The problem of antibiotic resistance can be minimized only by concerted efforts of all members of society for ensuring the continued efficiency of antibiotics.
Mycoplasma hyopneumoniae (M. hyopneumoniae) causes a chronic respiratory disease with high morbidity and low mortality in swine, and has been presented as a major cause of growth retardation in the swine industry. Aerosol vaccination presents a needle free, high throughput, and efficient platform for vaccine delivery, and has been widely applied in poultry vaccination. However, aerosol vaccines have rarely been used in swine vaccination primarily because the long and curving respiratory track of swine presents a barrier for vaccine particle delivery. To develop an effective M. hyopneumoniae aerosol vaccine, three major barriers need to be overcome: to optimize particle size for aerosol delivery, to maintain the viability of mycoplasma cells in the vaccine, and to optimize the environmental conditions for vaccine delivery. In this study, an aerosol mycoplasma vaccine was successfully developed based on a conventional live attenuated M. hyopneumoniae vaccine. Specifically, the Pari LCD nebulizer was used to produce an aerosol vaccine particle size less than 5μm; and a buffer with 5% glycerol was developed and optimized to prevent inactivation of M. hyopneumoniae caused by aerosolization and evaporation. Before nebulization, the room temperature and relative humidity were control to 20-25°C and 70-75%, respectively, which helped maintain the viability of aerosol vaccine. Animal experiments demonstrated that this newly developed aerosol vaccine was effectively delivered to swine low respiratory track, being confirmed by nested-PCR, in situ hybridization and scanning electron microscope. Moreover, M. hyopneumoniae specific sIgA secretion was detected in the nasal swab samples at 14 days post-immunization. To our knowledge, this is the first report on a live M. hyopneumoniae aerosol vaccine.
The objectives of this study were (1) to explore the factors involved in the decision-making process used by pig farmers for disease control and (2) to investigate pig farmers’ attitudes and perceptions about different information sources relating to disease control.
In 2011 a qualitative study involving 20 face-to-face interviews with English pig farmers was conducted. The questionnaire was composed of three parts. The first part required farmers to identify two diseases they had experienced and which were difficult to recognize and/or control. They were asked to report how the disease problem was recognized, how the need for control was decided, and what affected the choice of control approach. For the latter, a structure related to the Theory of Planned Behaviour was used. Their verbal responses were classified as associated with: (1) attitude and beliefs, (2) subjective norms, or (3) perceived behavioural control (PBC). In the second part, five key sources of information for disease control (Defra, BPEX, research from academia, internet and veterinarians) and the factors related to barriers to knowledge were investigated. Interviews were recorded and transcribed. A qualitative analysis of the text of the interview transcripts was carried out using templates.
Drivers for disease control were ‘pig mortality’, ‘feeling of entering in an economically critical situation’, ‘animal welfare’ and ‘feeling of despair’. Veterinarians were perceived by several participating farmers as the most trusted information source on disease control. However, in particular non-sustainable situations, other producers, and especially experiences from abroad, seemed to considerably influence the farmers’ decision-making. ‘Lack of knowledge’, ‘farm structure and management barriers’ and ‘economic constrains’ were identified in relation to PBC. Several negative themes, such as ‘lack of communication’, ‘not knowing where to look’, and ‘information bias’ were associated with research from academia.
This study identified a range of factors influencing the decision-making process for disease control by pig farmers. In addition, it highlighted the lack of awareness and difficult access of producers to current scientific research outputs. The factors identified should be considered when developing communication strategies to disseminate research findings and advice for disease control.
Objective: To determine the prevalence of Mycoplasma hyopneumoniae at weaning in litters originated from vaccinated and non-vaccinated sows. Materials and methods: A weekly production group of sows from an 800-sow commercial herd was randomly divided into two treatment groups. One group received a commercial vaccine (Respisure; Pfizer, New York) 5 and 3 weeks prior to farrowing, and the other group was unvaccinated (controls). Blood samples were collected from each sow prior to vaccination and at farrowing. Additionally, blood samples were collected at weaning and 2 weeks post weaning from four piglets from each sow. Samples were tested for antibodies to Mycoplasma hyopneumoniae by Tween-20 ELISA. Nasal swabs collected at farrowing from each sow and at weaning from each piglet were tested for M hyopneumoniae by nested polymerase chain reaction (N-PCR). The herd was not vaccinated for M hyopneumoniae before the study began, and no antibiotics effective against M hyopneumoniae were used during the study. Two replicates were performed using sows and litters in 2 consecutive weeks of production. Results: Over 80% of the vaccinated sows seroconverted and their antibodies were transferred to the piglets via colostrum. Prevalence of M hyopneumoniae in nasal swabs from sows did not differ among groups. Prevalence in piglets was lower in litters from vaccinated sows, but was significantly lower only in the first replicate. Implications: Vaccination of sows against M hyopneumoniae reduced prevalence of N-PCR-positive piglets at weaning, and could be used to control M hyopneumoniae in modern swine production systems.
Respiratory disease in swine is a major economic concern for producers around the world. Enzootic pneumonia, one of the most important chronic diseases in swine, is caused by Mycoplasma hyopneumoniae. Direct contact with infected pigs has been established as the chief route of transmission, constituting the main point of entry of the agent into the herd. Latently infected animals, aerosol spread, and fomites are alternative routes of infection of naive swine herds. Although the role of people acting as mechanical vectors in the transmission of pathogens between farms or groups of pigs has not been clearly defined, there are reports of isolation of foot-and-mouth disease virus, swine influenza, Pasteurella multocida, and porcine reproductive and respiratory syndrome virus from humans exposed to infected swine. In this case, M hyopneumoniae was not transmitted during a 20-week period when personnel weekly contacted susceptible pigs in a naive herd immediately after close contact with pigs in an infected herd. Personnel used a standard hygiene protocol before entering the uninfected farm.
Background
In recent years, the occurrence and the relevance of Mycoplasma hyopneumoniae infections in suckling pigs has been examined in several studies. Whereas most of these studies were focused on sole prevalence estimation within different age groups, follow-up of infected piglets or assessment of pathological findings, none of the studies included a detailed analysis of individual and environmental risk factors. Therefore, the aim of the present study was to investigate the frequency of M. hyopneumoniae infections in suckling pigs of endemically infected herds and to identify individual risk factors potentially influencing the infection status of suckling pigs at the age of weaning.
Results
The animal level prevalence of M. hyopneumoniae infections in suckling pigs examined in three conventional pig breeding herds was 3.6% (41/1127) at the time of weaning. A prevalence of 1.2% was found in the same pigs at the end of their nursery period. In a multivariable Poisson regression model it was found that incidence rate ratios (IRR) for suckling pigs are significantly lower than 1 when teeth grinding was conducted (IRR: 0.10). Moreover, high temperatures in the piglet nest during the first two weeks of life (occasionally >40°C) were associated with a decrease of the probability of an infection (IRR: 0.23-0.40). Contrary, the application of PCV2 vaccines to piglets was associated with an increased infection risk (IRR: 9.72).
Conclusions
Since single infected piglets are supposed to act as initiators for the transmission of this pathogen in nursery and fattening pigs, the elimination of the risk factors described in this study should help to reduce the incidence rate of M. hyopneumoniae infections and thereby might contribute to a reduced probability of high prevalences in older pigs.
Mycoplasma hyopneumoniae is the primary cause of enzootic pneumonia in pigs. Although vaccination is an important control tool, the results observed under field conditions are variable. This may be due to antigenic differences between the strains circulating in pig herds and the vaccine strain. This study compared the protective efficacy of four bacterins against challenge infection with a highly virulent field strain of M. hyopneumoniae. Seventy eight, one-week old piglets were randomly assigned to five treatment groups (A, B, C, D, E), 14 piglets each, and a negative control group (F) consisting of 8 piglets. All pigs were injected at 1 (D7) and 4 weeks of age (D28), with 2 ml of either a placebo or a bacterin based on selected M. hyopneumoniae strains, namely A (F7.2C), B (F20.1L), C (B2V1W20 1A-F), D (J strain), E (placebo; positive control), F (placebo; negative control). At D56, all pigs except those of group F were challenged intratracheally with 7 ml culture medium containing 107 CCU/ml of M. hyopneumoniae strain F7.2C. All pigs were euthanized and necropsied at D84. The severity of coughing and pneumonia lesions were the main parameters. Immunofluorescence (IF) testing, nested PCR testing of bronchoalveolar lavage (BAL) fluid and serology for M. hyopneumoniae were also performed.
The different bacterins only slightly improved clinical symptoms (average 0.38 in vaccinated groups vs. 0.45 in group E) and histopathological lung lesions (average 3.20 in vaccinated groups vs. 3.45 in group E), but did not improve macroscopic lung lesions (score 4.30 vs. 4.03 in group E). None of the vaccines was significantly and/or consistently better or worse than the other ones. All bacterins evoked a serological response in the vaccinated animals. All pigs, except those from group F, were positive with nPCR in BAL fluid at D84.
The bacterins did not induce a clear overall protection against challenge infection, and there were no significant differences in protective efficacy between bacterins containing homologous and heterologous M. hyopneumoniae strains. Further research is necessary to better characterize the antigens involved in protection and to elucidate the protective immunity responses following M. hyopneumoniae vaccination and/or infection.
Mycoplasma hyopneumoniae is the causative agent of enzootic pneumonia and is responsible for significant economic losses to the pig industry. To better understand the mode of action of a commercial, adjuvanted, inactivated whole cell vaccine and the influence of diversity on the efficacy of vaccination, we investigated samples from vaccinated and non-vaccinated pigs experimentally infected with either a low (LV) or a highly virulent (HV) M. hyopneumoniae strain. Non-vaccinated and sham-infected control groups were included. Lung tissue samples collected at 4 and 8 weeks post infection (PI) were immunohistochemically tested for the presence of T-lymphocytes, B-lymphocytes and macrophages in the bronchus-associated lymphoid tissue (BALT). The number of M. hyopneumoniae organisms in bronchoalveolar lavage (BAL) fluid was determined using quantitative PCR at 4 and 8 weeks PI. Serum antibodies against M. hyopneumoniae were determined at 0, 2, 4, 6 and 8 weeks PI.
The immunostaining revealed a lower density of macrophages in the BALT of the vaccinated groups compared to the non-vaccinated groups. The highest number of M. hyopneumoniae organisms in the BAL fluid was measured at 4 weeks PI for the HV strain and at 8 weeks PI for the LV strain. Vaccination reduced the number of organisms non-significantly, though for the HV strain the reduction was clinically more relevant than for the LV strain. At the level of the individual pigs, a higher lung lesion score was associated with more M. hyopneumoniae organisms in the lungs and a higher density of the investigated immune cells in the BALT.
In conclusion, the infiltration of macrophages after infection with M. hyopneumoniae is reduced by vaccination. The M. hyopneumoniae replication in the lungs is also reduced in vaccinated pigs, though the HV strain is inhibited more than the LV strain.
The aim of this study was to assess the effect of cross-fostering on transfer of maternal Mycoplasma hyopneumoniae-specific humoral and cell-mediated immunity (CMI) from gilts to piglets. Cross-fostering, carried out within gilt pairs, was based on the gilts' M hyopneumoniae vaccination status in accordance with the following scheme: six pairs of vaccinated gilt × non-vaccinated gilt (V × N); five pairs of non-vaccinated gilt × vaccinated gilt (N × V); and five pairs of vaccinated gilt × vaccinated gilt (V × V). The piglets were cross-fostered at 0, six, 12 or 20 hours after birth. Two piglets per gilt per time point were cross-fostered (that is, eight piglets per gilt were moved) and the remaining piglets served as non-cross-fostered controls. In addition, four litters served as non-cross-fostered controls. A maximum of 10 piglets per gilt were sampled. The piglets' M hyopneumoniae-specific humoral immunity was assessed by ELISA and their CMI was assessed by delayed-type hypersensitivity testing. M hyopneumoniae-specific antibodies were detected in non-cross-fostered piglets from vaccinated dams and from piglets cross-fostered within the V × N gilt pair at six hours or more, and within the V × V gilt pair at all time points. Piglets cross-fostered within the N × V gilt pair had detectable M hyopneumoniae-specific antibodies only if they had been moved within six hours of birth. The transfer of M hyopneumoniae-specific CMI to piglets appeared to be source-dependent, and was detected only in piglets maintained on their vaccinated dams for at least 12 hours after birth.
This article reviews current knowledge concerning enzootic pneumonia. Enzootic pneumonia, caused by Mycoplasma hyopneumoniae and exacerbated by secondary invaders, occurs worldwide and has been known for many years. The organism, with its typical characteristics, invades the respiratory tract in several successive steps. Clinical symptoms and lesion development are the result of the pathogenic capacity of Mycoplasma hyopneumoniae and the defence reactions in the lung. The economic relevance of pneumonia is influenced to a large extent by common secondary infections which follow an initial M. hyopneumoniae infection. Different tests for the diagnosis of pneumonia in individual pigs and in groups are available. Treatment and control is not simple since enzootic pneumonia is a multi-factorial disease. Some epidemiological aspects and the most important measures for prevention of the disease are described.
Enzootic pneumonia (EP) in pigs caused by Mycoplasma (M.) hyopneumoniae has successfully been combatted in Switzerland. A control program was fully implemented in 2004 which is based on total depopulation strategies of affected fattening farms as well as partial depopulation on breeding farms. Thereby, the number of cases has dropped drastically from more than 200 in 2003 to two cases in 2013. Currently monitoring is done based on clinical observation and subsequent diagnostic of coughing pigs. Moreover, in case of more than 10% gross pathological lesions per slaughter batch laboratory confirmation for EP is compulsory. Despite these strict measures it was not possible to eliminate M. hyopneumoniae from Swiss pig production. In fact, during the last few years the number of EP cases has slightly increased. Therefore, genotyping of the involved M. hyopneumoniae strains was conducted in order to elucidate possible sources and routes of infection. All available and typeable samples from totally 22 cases during the period 2014–2016 were investigated by extended multilocus sequence typing (MLST). A total of 16 cases, including eight from 2014, five from 2015 and three from 2016 could thereby be included in the study. MLST revealed that the majority of cases in 2014/2015 were due to two major spread scenarios, i.e. two M. hyopneumoniae sequence types, each scenario involving six individual production farms in five to six different Cantons (states), respectively. Moreover, by comparison of archived sequences some sequence types were observed over ten years demonstrating their persistence over a long time and the possible partial failure of elimination measures in Switzerland. Insufficient sanitation on affected farms and subsequent animal transport of symptomless infected pigs could lead to recurrent cases. Wild boar harbor identical strains found with EP but solid data are missing to assign a role as reservoir to this wild animal. Implementing a monitoring scheme for M. hyopneumoniae in wild boar in combination with genotyping of all available samples from domestic pigs could direct responsible authorities to possible gaps and deficiencies of control measures taken for combating enzootic pneumonia. With the newly installed PubMLST database sequence types for M. hyopneumoniae are now available and allow tracing back strains on the international level.
Mycoplasma hyopneumoniae causes a chronic respiratory infection in pigs and its transmission occurs mainly by direct contact and by vertical transmission (sow-to-piglet). The objective of this study was to assess the detection dynamics and persistence of M. hyopneumoniae natural infection in replacement gilts. Forty-four twenty-day-old gilts were selected from a M. hyopneumoniae positive farm and followed up to one day prior to their first weaning. Laryngeal swabs were collected every 30 days, starting at day 20, for M. hyopneumoniae detection by real-time PCR, resulting in 12 samplings. Piglets born to selected females were sampled via laryngeal swabs one day prior to weaning to evaluate sow-to-piglet transmission. The M. hyopneumoniae prevalence was estimated at each one of the 12 samplings in gilts and a multiple comparison test and Bonferroni correction were performed. Bacterial detection in gilts started at 110 days of age (doa) and a significant increase (p < 0.05) occurred at 140 doa. The M. hyopneumoniae prevalence remained above 20% from 140 to 230 doa, decreasing thereafter. However, it did not reach 0% at any sampling after 110 doa. In this study, M. hyopneumoniae was not detected in piglets sampled prior to weaning. The M. hyopneumoniae detection pattern showed that in natural infections, gilts were positive for M. hyopneumoniae for one to three months, but occasionally long-term detection may occur. Moreover, the lack of M. hyopneumoniae detection throughout the study in 18.2% of gilts indicated the existence of negative subpopulations in positive herds.
Detection of Mycoplasma hyopneumoniae in live pigs during the early stages of infection is critical for timely implementation of control measures, but is technically challenging. This study compared the sensitivity of various sample types and diagnostic methods for detection of M. hyopneumoniae during the first 28 days after experimental exposure. Twenty-one 8-week old pigs were intra-tracheally inoculated on day 0 with M. hyopneumoniae strain 232. Two age matched pigs were mock inoculated and maintained as negative controls. On post-inoculation days 0, 2, 5, 9, 14, 21 and 28, nasal swabs, laryngeal swabs, tracheobronchial lavage fluid, and blood samples were obtained from each pig and oral fluid samples were obtained from each room in which pigs were housed. Serum samples were assayed by ELISA for IgM and IgG M. hyopneumoniae antibodies and C-reactive protein. All other samples were tested for M. hyopneumoniae DNA by species-specific real-time PCR. Serum antibodies (IgG) to M. hyopneumoniae were detected in challenge-inoculated pigs on days 21 and 28. M. hyopneumoniae DNA was detected in samples from experimentally inoculated pigs beginning at 5 days post-inoculation. Laryngeal swabs at all samplings beginning on day 5 showed the highest sensitivity for M. hyopneumoniae DNA Detection, while oral fluids showed the lowest sensitivity. Although laryngeal swabs are not considered the typical M. hyopneumoniae diagnostic sample, under the conditions of this study laryngeal swabs tested by PCR proved to be a practical and reliable diagnostic sample for M. hyopneumoniae detection in vivo during early-stage infection.
Mycoplasma hyopneumoniae is one of the most prevalent and economically significant respiratory pathogens in the swine industry. Economic losses related to M hyopneumoniae are associated with decreased feed efficiency, reduced average daily gain, and increased medication costs. In an effort to mitigate these economic losses, swine veterinarians and producers utilize several control measures, including optimizing management and housing, vaccination, and strategic antimicrobial medication. When control measures are insufficient, or eradication of M hyopneumoniae is preferred, swine veterinarians and producers may elect to eliminate M hyopneumoniae from affected sow farms. Herd closure and medication protocols have become widely used in North America to eliminate M hyopneumoniae from breed-to-wean farms. As vital principles for success, these protocols rely on no new animal introductions for at least 8 months, vaccination of the entire breeding herd, and medication of the breeding herd and piglets. Commonly, the breeding herd is medicated with oral antimicrobials delivered via the drinking water or feed, whereas the piglets are treated with injectable antimicrobials. In this commentary, we will review current M hyopneumoniae elimination protocols with an emphasis on the herd closure and medication protocols.
ACQUIRING high health replacement females has become a common practice in the pig industry, as producers aim to manage healthier pigs and apply strict biosecurity to keep pathogens at bay. However, depending of the health status of the recipient herd, this practice may carry unwanted challenges. Health challenges in the incoming and recipient females need to be properly managed in order to avoid health issues and production disruption in the recipient herd. Here, we propose a targeted timeline for acclimatisation of negative gilts entering a farm endemically infected with Mycoplasma hyopneumoniae .
Considering two important epidemiological features of M hyopneumoniae – …
This paper summarizes observations recorded over a 4-year (1438-day) period regarding the ability of a l-night period of downtime to prevent mechanical spread of porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae between pig populations by personnel and fomites.
The objective of this study was to identify intra-farm risk factors that affected the colonization with Mycoplasma hyopneumoniae at weaning age. Three farrow-to-wean farms were visited at least 5 times each. An average of 54 piglets were sampled at each visit and assayed by means of real-time PCR in nasal swabs. The proportion of PCR positive piglets was evaluated as a response to several variables including dam's PCR status, piglet serological status, and local climatic conditions during the lactation period, as well as other factors. All piglets at weaning age were negative to M. hyopneumoniae in 2 of the 3 farms. M. hyopneumoniae positive piglets were demonstrated in 5 of 7 weaning groups in 1 farm. The proportion of M. hyopneumoniae positive piglets in each weaning group at the positive farm was correlated with the proportion of positive dams in the group. The prevalence of M. hyopneumoniae at weaning increased with the piglet's age in the groups where at least one dam was positive. These results highlight the influence of the sow in the sow-to-piglet colonization process, as previously reported, and contribute to a more comprehensive understanding of the epidemiology of M. hyopneumoniae infections.
The aim of the present study was to identify potential risk factors for the occurrence of enzootic pneumonia (EP) in herds situated in a region of high pig density, where a majority of herds is endemically infected with Mycoplasma hyopneumoniae. Between 2006 and 2010, overall 100 herds were enrolled in a case-control study. Data were collected through personal interview with the farmers, clinical examination of pigs and their environments, and serological testing for M. hyopneumoniae, swine influenza virus and porcine reproductive and respiratory syndrome virus. There were 40 case herds (coughing index high, seroprevalence high) with a mean coughing index of 4.3 and a seroprevalence of 86.6%. There were two control groups. Control group I consisted of 25 herds (coughing index low, seroprevalence low) with mean values of 0.7 and 11.2%, and 35 herds were allocated to control group II (coughing index low, seroprevalence high) where the mean coughing index was 0.9 and seroprevalence 86.3%. Case herds and control II herds had an increased age of piglets at weaning compared to control I herds. Any contact between fattening pigs of different age during restocking of compartments increased the risk for the occurrence of EP in a herd. Finally, farms that use living animals for the exposure to gilts during the acclimatization and farms that had increased number of weaned piglets per sow and year were less likely to test positive for M. hyopneumoniae and less likely to develop clinical symptoms of EP in fattening pigs.
Differences in Mycoplasma hyopneumoniae strain virulence and infection patterns will affect experimental challenge systems used to evaluate vaccine efficacy. Two strains (Hillcrest and Beaufort) were assessed by experimental pig challenge for their ability to induce clinical and pathological lesions and cytokine responses. Tracheobronchial lavage fluid (TBLF) was collected before and 17-18 days after challenge with Hillcrest (n=8), Beaufort (n=8) or no organisms (n=3). Coughing was assessed twice daily, and at slaughter 21 (n=9) or 28 (n=10) days post-challenge, gross and histopathology of lungs were quantified and a quantitative PCR (mhp183 qPCR) was applied to detect M. hyopneumoniae DNA in tissues and TBLF. Hillcrest was clearly superior to Beaufort in its ability to induce coughing and pneumonic lesions. At 17-18 days, interleukin (IL)-1β and IL-6 concentrations in TBLF were only significantly higher (8.7 and 5.1 fold respectively) than controls (P<0.001) in Hillcrest-challenged pigs. Lungs of all Hillcrest-challenged pigs were qPCR positive at either slaughter date, but only at day 28 in Beaufort-challenged pigs. M. hyopneumoniae DNA was highest in concentration in lungs 21 days after Hillcrest challenge, and was detected in the spleen, kidney and/or liver of Hillcrest-challenged pigs, but not in Beaufort pigs. While M. hyopneumoniae DNA concentration in TBLF was elevated following Hillcrest and Beaufort challenge, there was no significant difference in mean mycoplasmal DNA concentration detected in TBLF from pigs challenged with either isolate (P>0.05). Thus a suitable challenge strain, coupled with lung pathology and cytokine assays, are valuable in assessing post-challenge responses. Assessment of M. hyopneumoniae DNA in lung and abdominal tissues by mhp183 qPCR, in conjunction with histopathology, were valuable in confirming M. hyopneumoniae infection.
A cohort of 57 pigs in a farrow-to-finish swine herd with mild clinical mycoplasmal disease was followed to determine patterns of seroconversion to Mycoplasma hyopneumoniae (MH), detected with an enzyme-linked immunosorbent assay (ELISA). Survival analysis was used to evaluate the relationship between time to seroconversion and possible risk factors for MH infection (or enzootic pneumonia).Pigs were housed in outdoor pens at approximately 9 weeks of age, when passively acquired MH antibodies had decayed. From 9 to 11 weeks of age and during a 5 week period, pigs were exposed by direct (nose-to-nose) or indirect contact to older seropositive gilts. Blood samples were collected from each pig at 3 week intervals until market age, when they were either slaughtered or selected for breeding. Antibody concentration was measured as the ratio of optical densities of the serum sample to the positive control (). Based on the sample distribution of ratios from pigs in an MH-free herd, pigs were considered positive when ratios were greater than 0.34. At the beginning of the study, all pigs were seronegative to MH. Seroconversion was first detected after 21 days, and was most frequent about 11 weeks after exposure to older seropositive gilts. By the end of the study, 11 pigs (19%) had seroconverted, with ratios ranging from 0.40 to 1.11. The presence of gross lung lesions showed a moderate to good agreement with ELISA results (K = 0.62). Histologic lesions were evident in virtually all slaughtered pigs, ranging from mild, non MH-specific lesions to severe lesions typical of MH infection. No secondary respiratory pathogens were isolated. Clinical signs were mild and there was no significant difference (P > 0.4) in weight gain between seropositive and seronegative pigs, or between pigs with and without lung lesions. A Cox regression model was fitted to the seroconversion data, and opportunity of contact (direct or indirect) was the only significant variable. After adjustment for breed and antibody ratio prior to exposure, pigs in direct contact with seropositive gilts were seven times more likely to seroconvert than those in only indirect contact.
A longitudinal study was carried out to investigate the diversity and persistence of Mycoplasma hyopneumoniae (M. hyopneumoniae) strains in four infected pig herds. In each herd, 20 pigs were randomly selected and blood and/or bronchoalveolar lavage (BAL) fluid was collected at 6, 10, 14 and 26 weeks of age. In the BAL fluid, quantitative PCR and MLVA (multiple-locus variable number of tandem repeats (VNTR) analysis) testing were performed for detection and typing of M. hyopneumoniae strains, respectively. At 26 weeks of age, the prevalence and severity of lung lesions were recorded at slaughter (minimum 50 pigs belonging to the same batch as the investigated pigs). The percentage of pigs testing positive on qPCR increased from 35% at 6 weeks to 96% at 26 weeks of age. With MLVA testing, positive pigs were found from 14 weeks onwards. Within each herd, only one distinct strain was detected, although clonal variants were identified in two herds. In three of the herds, the strain remained present until slaughter age. The percentage of pigs with Mycoplasma-like lesions ranged from 38% to 98%, and the average pneumonia score ranged from 1.7 to 11.9, respectively. The present field study documented that within a herd, mainly one distinct M. hyopneumoniae strain was present that persisted in the same animals for at least 12 weeks. This implies that the immune response of the animals following infection is not able to rapidly clear the infection from the respiratory tract.
This study investigated the infection pattern and lung lesion development in pigs caused by a low and highly virulent Mycoplasma hyopneumoniae strain at 4 and 8 weeks (w) post infection (PI). It also determined the efficacy of a commercial inactivated whole-cell vaccine against infection with each one of these M. hyopneumoniae strains. Ninety piglets free of M. hyopneumoniae were selected, and 40 of them were randomly vaccinated during their first week of life. At weaning, all piglets were allocated to 10 different groups and housed in pens with absolute filters. At 4 weeks of age, pigs were inoculated intratracheally with either a highly virulent M. hyopneumoniae strain, a low virulent strain or with sterile culture medium. Half of all animals were euthanized at 4 w PI, while the remaining half was euthanized at 8 w PI. Coughing was assessed daily, and lung lesions, immunofluorescence (IF), bacteriological analysis and nested PCR were assessed after necropsy. It was demonstrated that contrary to the highly virulent strain, the low virulent strain required more than 4 weeks PI (commonly accepted as the standard infection model) to reach maximum clinical symptoms. Vaccination significantly reduced clinical symptoms, macroscopic and microscopic lung lesions in pigs infected with the highly virulent strain. This effect was more pronounced at 4 than at 8 weeks PI. Protective efficacy was also observed in pigs infected with the low virulent strain, but the effect was less pronounced than on the highly virulent strain.
The objective of this study was to determine the effect of vaccinating susceptible animals on the transmission of Mycoplasma hyopneumoniae from experimentally infected pigs during the chronic phase of infection. Thirty-six seeder pigs were experimentally infected with M. hyopneumoniae. Eighty and 200 d post-infection (dpi) 18 seeder pigs were placed in direct contact with 15 vaccinated and 15 unvaccinated age-matched naïve animals. Direct animal contact occurred over 14 d. Pigs were euthanized at the end of the contact period and bronchial swabs were collected and lung tissue examined. At 94 dpi, 15 out of 15 unvaccinated sentinels and 14 out of 15 vaccinated sentinels tested positive for M. hyopneumoniae by nested polymerase chain reaction (N-PCR). At 214 dpi, M. hyopneumoniae DNA was detected by PCR in 8 out of 15 unvaccinated and 6 out of 15 vaccinated sentinels. Vaccination against M. hyopneumoniae did not prevent colonization of sentinels in contact with infected animals. Transmission of M. hyopneumoniae from asymptomatic carriers to unvaccinated and vaccinated sentinels was not different.
Four sampling techniques for Mycoplasma hyopneumoniae detection, namely nasal swabbing, oral-pharyngeal brushing, tracheo-bronchial swabbing and tracheo-bronchial washing, were compared in naturally infected live pigs. In addition, a quantitative real-time PCR assay for M. hyopneumoniae quantification was validated with the same samples. 60 finishing pigs were randomly selected from a batch of contemporary pigs on a farm chronically affected by respiratory disorders. Each pig was submitted to nasal swabbing, oral-pharyngeal brushing, tracheo-bronchial swabbing and tracheo-bronchial washing. Nested-PCR and real-time PCR assays were performed on all samples. A Bayesian approach was used to analyze the nested-PCR results of the four sampling methods (i.e. positive or negative) to estimate the sensitivity and specificity of each method. M. hyopneumoniae was detected by nested-PCR in at least one sample from 70% of the pigs. The most sensitive sampling methods for detecting M. hyopneumoniae in live naturally infected pigs were tracheo-bronchial swabbing and tracheo-bronchial washing, as compared to oral-pharyngeal brushing and nasal swabbing. Swabbing the nasal cavities appeared to be the least sensitive method. Significantly higher amounts of M. hyopneumoniae DNA were found at the sites of tracheo-bronchial sampling than in the nasal cavities or at the oral-pharyngeal site (p<0.001). There was no difference between the tracheo-bronchial washing and the tracheo-bronchial swabbing results (p>0.05). Our study indicated that tracheo-bronchial swabbing associated with real-time PCR could be an accurate diagnostic tool for assessing infection dynamics in pig herds.
The study aimed to evaluate the effect of an infection with low virulent isolates of M. hyopneumoniae (LV1 and LV2) on the subsequent infection with a highly virulent isolate (HV). Fifty-five, 3-week-old piglets free of M. hyopneumoniae were randomly allocated to 6 different groups. At 4 weeks of age (D0), groups LV1–HV and LV1 were intratracheally inoculated with LV1, groups LV2–HV and LV2 with LV2, and group HV with sterile culture medium. Four weeks later (D28), the pigs of these different groups were either intratracheally inoculated with the highly virulent isolate (groups LV1–HV, LV2–HV, HV) or with sterile culture medium (groups LV1 and LV2). A negative control group consisted of pigs inoculated with sterile culture medium on D0 and D28. All animals were necropsied at 28 days after the second inoculation (D56). Clinical symptoms were evaluated daily using a respiratory disease score (RDS). After necropsy, macroscopic and histopathological lung lesions were quantified and immunofluorescence (IF) testing on lung tissue and nested PCR on BAL fluid were performed for the detection of M. hyopneumoniae.
Mycoplasma hyopneumoniae (M. hyopneumoniae) is the primary pathogen of enzootic pneumonia (EP), a highly prevalent respiratory disease that affects pigs worldwide. Previous studies have demonstrated that M. hyopneumoniae infection can be longer than 185 days; however, the total duration of infection has not been determined yet. Therefore, the objective of this study was to determine the duration of M. hyopneumoniae infection in asymptomatic carriers. To achieve our goal, 60 pigs were inoculated with M. hyopneumoniae strain 232 and the persistence of M. hyopneumoniae in the respiratory tract was assessed by detection of the bacterial DNA in bronchial swabs and the ability of the infected pigs to transmit the pathogen to sentinels. Infection of the inoculated animals was demonstrated by the detection of M. hyopneumoniae DNA in nasal swabs, seroconversion to the bacteria and the onset of dry coughing. Experimentally infected pigs shed M. hyopneumoniae prior to and after the cough was observed. M. hyopneumoniae DNA was detected in 100% of experimentally infected pigs at 94 days post infection (dpi), 61% at 214dpi and 0% at 254dpi. Experimentally infected pigs transmitted the bacteria to sentinels at 80 and 200dpi. Results of this study have demonstrated that M. hyopneumoniae infected pigs can be incubatory as well as convalescent carriers of the pathogen and that convalescent carriers can remain infectious for up to 200 days. Total clearance of M. hyopneumoniae in the group was evidenced, demonstrating that duration of M. hyopneumoniae infection lasts less than 254 days.
The course of enzootic pneumonia, caused by Mycoplasma hyopneumoniae, is strongly influenced by management and housing conditions. Other factors, including differences in virulence between M. hyopneumoniae strains, may also be involved. The aim of this study was to evaluate the virulence of six M. hyopneumoniae field isolates and link it to genetic differences as determined by randomly amplified polymorphic DNA (RAPD) analysis. Ninety, conventional M. hyopneumoniae-free piglets were inoculated intratracheally with the field isolates, a virulent reference strain or sterile culture medium. Animals were examined daily for the presence of disease signs and a respiratory disease score (RDS) was assessed per pig. Twenty-eight days post infection, pigs were euthanized, blood sampled and a lung lesion score was given. Lung samples were processed for histopathology, immunofluorescence testing for M. hyopneumoniae and isolation of M. hyopneumoniae. RAPD analysis was performed on all M. hyopneumoniae strains. Significant differences between isolates were found for the RDS, lung lesion score, histopathology, immunofluorescence and serology. Based on the results of the different parameters, isolates were divided into three "virulence" groups: low, moderately and highly virulent strains. Typically, a 5000 bp RAPD fragment was associated with the highly and moderately virulent strains whereas it was absent in low virulent strains. It was concluded that high variation in virulence exists between M. hyopneumoniae strains isolated from different swine herds. Further studies are required to determine whether the 5000 bp fragment obtained in the RAPD analysis can be used as a virulence marker.
This paper discusses what can be expected with regard to efficacy of antibacterial vaccines used in swine, based on the present knowledge of pathogen-host interactions. First, vaccination against bacteria that mainly cause disease by production of exotoxins is considered. Vaccines containing the inactivated toxin or a non-toxic but antigenic recombinant protein derived from the exotoxin can be expected to provide protection against disease. The degree of protection induced by such vaccines varies, however, depending amongst other things on the pathogenesis of the disease. Vaccination against clostridial infections, Actinobacillus pleuropneumoniae infections, progressive atrophic rhinitis and enterotoxigenic Escherichia coli, is considered. The second part of the article deals with vaccination against extracellular bacteria. Protection against these bacteria is generally mediated by antibodies against their surface antigens and certain secreted antigens, but cellular immunity may also play a role. Efficacy of vaccines against swine erysipelas, Streptococcus suis infections, Mycoplasma hyopneumoniae infections and swine dysentery is discussed. Finally, vaccination against facultatively intracellular bacteria is considered. For protection against these bacteria cell-mediated immunity plays an important role, but antibodies may also be involved. It is generally accepted that live-attenuated vaccines are more suitable for induction of cell-mediated immunity than inactivated vaccines, although this also depends on the adjuvant used in the vaccine. As an example, vaccination against Salmonella enterica serotype Typhimurium is discussed.
A Mycoplasma hyopneumoniae-negative commercial swine production system broke with enzootic pneumonia at their grow/finish site in southern Manitoba in October, 2003. System responses included feed medication, depopulation, delayed shipment of pigs to the infected site, vaccination of at risk sow herds, and disinfection when grow/finish site depopulation was completed.
Mycoplasma hyopneumoniae (M. hyopneumoniae) is present in almost all swine herds worldwide, but transmission of the pathogen through herds is not yet fully clarified. The aim of this study, performed in 2003, was to investigate and to quantify the transmission of M. hyopneumoniae under experimental conditions by means of an adjusted reproduction ratio (Rn). This Rn-value, calculated according to the final size method, expresses the mean number of secondary infections due to one typical infectious piglet during the nursery period. The period lasted from 4 to 10 weeks of age, corresponding with the nursery period used in most European production systems. Additionally, a comparison was made between transmissions of highly virulent and low virulent isolates. Forty-eight weaned piglets, free of M. hyopneumoniae, were housed in six separate pens. During 6 weeks, two animals experimentally infected with M. hyopneumoniae were housed together with six susceptible piglets. At the end of the study, the number of contact-infected animals was determined by the use of nPCR on bronchoalveolar lavage fluid. The Rn-values of the highly virulent and the low virulent isolates were estimated to be 1.47 (0.68-5.38) and 0.85 (0.33-3.39), respectively. No significant difference between the groups was found (P=0.53). The overall Rn was estimated to be 1.16 (0.94-4.08). Under the present experimental conditions, the transmission of M. hyopneumoniae, assessed for the first time by a reproduction ratio, shows that one piglet infected before weaning will infect on average one penmate during the nursery phase.
To evaluate the transmission of Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus (PRRSV) by aerosol as either a single or mixed infection, 28 pigs were inoculated intratracheally with M hyopneumoniae on day 0 and infected intranasally with PRRSV on day 35; they were housed together in a barn. To assess the aerosol transmission of M hyopneumoniae as a single infection, one trailer (A) containing 10 five-week-old sentinel pigs was placed along the south side of the infected barn (1 m from the fans) on day 28. To assess the mixed infection, two trailers (B and C), each containing 10 five-week-old sentinel pigs, were placed along each side of the barn on day 42. The sentinel pigs in the three trailers were exposed to the exhaust from the fans for seven days. No M hyopneumoniae infection was detected in the sentinel pigs in trailer A, but it was detected in the sentinel pigs in trailers B and C. No PRRSV was detected in any of the sentinel pigs.
A transmission experiment was performed to quantify the effect of vaccination on the transmission of Mycoplasma hyopneumoniae (M. hyopneumoniae) in nursery piglets by means of an adjusted reproduction ratio (R(n)). Thirty piglets, vaccinated at 1 week of age, and 30 non-vaccinated piglets, free of M. hyopneumoniae, were housed in six separate pens. In each pen, three animals that were intratracheally inoculated with M. hyopneumoniae, were housed together with seven contact piglets during the conventional nursery period of 6 weeks. At the end of the study, the infectious status of the animals was determined based on results of nPCR performed on bronchoalveolar lavage fluid. The R(n)-value in the vaccinated group was 2.38 (1.07-7.53) while in the non-vaccinated group, an R(n)-value of 3.51 (1.51-9.34) was observed, both not significantly different from each other (p=0.77). Under the actual experimental conditions, transmission of M. hyopneumoniae in nursery piglets was only numerically lower in vaccinated groups. In addition, vaccination with a conventional vaccine could not prevent the establishment of M. hyopneumoniae organisms in the lung.
The present study focused on Mycoplasma hyopneumoniae (M. hyopneumoniae) detection by nPCR in nasal swabs of 507 suckling pigs. These animals came from 69 sows (from 1 to 8 parity number) of a farrow-to-finish herd with Enzootic Pneumonia (EP) problems at finishing stages. At 1 and 3 weeks of age (still in the farrowing units), nasal swabs and blood samples were taken from all piglets. Moreover, from these 507 animals, 37 randomly selected pigs were necropsied at 3 weeks of age. From those necropsied pigs, M. hyopneumoniae presence was tested in bronchial and tonsillar swabs. At 1 week post-farrowing, blood samples from sows were collected and used to detect M. hyopneumoniae antibodies. From the 69 analysed sows, 19 (27.5%) were seropositive. Global percentage of pigs with M. hyopneumoniae detection in nasal swabs at 1 and 3 weeks of age was 1.5% (8 out of 507) and 3.8% (19 out of 507), respectively. From these nPCR positive pigs, 89% (24 out of 27) were seronegative and 11% were seropositive. From necropsied animals, the pathogen DNA was detected in two pigs at bronchus level and in another pig at tonsil. In this study, sow parity was not statistically related with sow seropositivity and piglet colonization. These results confirm that M. hyopneumoniae infection may be detected not only in nasal cavities of naturally infected suckling piglets but also at their low respiratory tract airways. Our results suggest that M. hyopneumoniae detection in lower and upper respiratory tract could be an indicator that respiratory problems associated to EP may start relatively early in the production system. In consequence, sow-to-piglet and/or piglet-to piglet transmission in farrowing barns should not be underestimated.
To determine whether Mycoplasma hyopneumoniae colonization at weaning in off-site weaning systems is associated with the severity of respiratory disease due to this agent in growing pigs, we studied 20 groups, each group representing a different week in production, in sow herds at 3 farms of 3000 sows each that had a prevalence of M. hyopneumoniae colonization at weaning higher than 5%. The calculated sample size for assessment at weaning was 39 piglets for each group under study; 39 litters were randomly selected, and 1 piglet was randomly selected from each litter for testing and ear-tagged. In total, 780 piglets were tested. The presence of M. hyopneumoniae in nasal swabs at weaning was established by nested polymerase chain reaction (PCR). All groups were followed until slaughter, at which time blood samples were collected from each ear-tagged pig to test for M. hyopneumoniae antibodies, bronchial swabs were collected for detection of M. hyopneumoniae DNA by nested PCR, and the lung lesion score and percentage of affected lungs in the same animals were calculated. Correlation analyses showed a positive correlation between colonization at weaning and all 4 dependent variables indicating infection at slaughter: average lung lesion score, percentage of affected lungs, presence of M. hyopneumoniae on the bronchial epithelium, and seroconversion. This study provides evidence that severity of the disease can be predicted by the prevalence at weaning in segregated systems. Therefore, strategies focused on reducing colonization at weaning seem to be important elements in the global control of M. hyopneumoniae in segregated production systems.
The objectives of the present study were to compare Mycoplasma hyopneumoniae (Mh) colonization and serologic status on Mh vaccinated and non-vaccinated sows and to assess the effect of sow vaccination on colonization and serologic status of their piglets at weaning as well as presence of enzootic pneumonia (EP) lung lesions at slaughter. Fifty sows (25 vaccinated and 25 unvaccinated) as well as five of their piglets were included in the study. Blood samples and nasal swabs from sows at 7 weeks pre-farrowing and 1 week post-farrowing and from piglets at 3-4 weeks of age were taken. Nasal swabs and sera were tested by a nested polymerase chain reaction (nPCR) to detect Mh DNA and by an enzyme-linked immunosorbent assay (ELISA) test to detect antibodies to the pathogen, respectively. Finally, at 23 weeks of age, pigs were sent to the slaughter where the extension of EP-compatible gross lesions was assessed. Vaccination with two doses of Mh vaccine resulted in a significantly higher (p<0.05) percentage of seropositive sows than in the non-vaccinated group at 1 week post-farrowing. On the contrary, no statistical significant differences were found in the number of nasal nPCR positive sows among different treatments (p>0.05). At 3-4 weeks of age, a significantly higher percentage (p<0.001) of seropositive piglets came from vaccinated than from non-vaccinated sows. Although the number of Mh infected piglets coming from non-vaccinated sows was higher than the one from vaccinated sows, the difference was not statistically significant (p>0.05). Overall, piglets from vaccinated sows had a significant lower (p<0.05) mean of EP-compatible lung lesions (1.83+/-2.8) than piglets from non-vaccinated sows (3.02+/-3.6). Under the conditions described in this study, sow vaccination did not affect sow or piglet colonization but increased the percentage of seropositive sows and piglets at weaning and reduced significantly the mean EP-compatible lung lesion scoring at slaughter.
Mycoplasma hyopneumoniae, the primary pathogen of enzootic pneumonia, occurs worldwide and causes major economic losses to the pig industry. The organism adheres to and damages the ciliated epithelium of the respiratory tract. Affected pigs show chronic coughing, are more susceptible to other respiratory infections and have a reduced performance. Control of the disease can be accomplished in a number of ways. First, management practices and housing conditions in the herd should be optimized. These include all-in/all-out production, limiting factors that may destabilize herd immunity, maintaining optimal stocking densities, prevention of other respiratory diseases, and optimal housing and climatic conditions. Strategic medication with antimicrobials active against M. hyopneumoniae and, preferably, also against major secondary bacteria may be useful during periods when the pigs are at risk for respiratory disease. Finally, commercial bacterins are widely used to control M. hyopneumoniae infections. The main effects of vaccination include less clinical symptoms, lung lesions and medication use, and improved performance. However, bacterins provide only partial protection and do not prevent colonization of the organism. Different vaccination strategies (timing of vaccination, vaccination of sows, vaccination combined with antimicrobial medication) can be used, depending on the type of herd, the production system and management practices, the infection pattern and the preferences of the pig producer. Research on new vaccines is actively occurring, including aerosol and feed-based vaccines as well as subunit and DNA vaccines. Eradication of the infection at herd level based on age-segregation and medication is possible, but there is a permanent risk for re-infections.
Mycoplasma hyopneumoniae and PRRSV elimination in a 1700 sows multi-site system
- A Alfonso
- J Geiger
- C Feixes
- J Fonz
- M Torremorell
Alfonso, A., Geiger, J., Feixes, C., Fonz, J., Torremorell, M., 2004. Mycoplasma hyopneumoniae and PRRSV elimination in a 1700 sows multi-site system. In: Proceedings
of the 18th IPVS Congress. Hamburg, Germany. pp. 174.
Mexican swine industry on Mycoplasma hyopneumoniae gilts acclimatation
- N Centeno
- J Chévez
- E Fano
Centeno, N., Chévez, J., Fano, E., 2016. Mexican swine industry on Mycoplasma hyopneumoniae gilts acclimatation. In: Proceedings of the 24 th IPVS Congress. Dublin,
Ireland, 31, 2013.
Mycoplasma hyopneumoniae acclimation: overcoming challenges in the field
- L Dalquist
Dalquist, L., 2014. Mycoplasma hyopneumoniae acclimation: overcoming challenges in
the field. In: Allen D. Leman Swine Conference. St. Paul, MN.